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Abstract 
Abdominal aortic aneurysms affect 0.2% of the population and are closely associated 
with intraluminal thromboses (ILTs) that develop in the sac. Advanced imaging and 
treatment techniques are available, however there is room for improvement in the 
methods used to predict the outcome or necessity of surgical intervention. For a 
computational model to be useful in this clinical setting, it would need to incorporate 
relevant patient-specific data and prioritise simplicity and speed over exhaustive detail. 
This paper presents the details of such a model, for abdominal aortic aneurysms, 
particularly in the simplification of the coagulation biochemistry. Explicit modelling of 
the coagulation cascade is replaced with a patient-specific thrombin generation curve. 
This curve is defined by three values obtained from a blood test. Another key feature 
is the thrombosis growth model, which incorporates conversion of fibrinogen to fibrin, 
variation between clot core and shell, and mechanical lysis. The model generates ILTs 
with morphologies visually similar to those typically found in the body, however more 
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1 Literature review 
1.1 Clinical context 
1.1.1 What is an Aneurysm? 
An aneurysm is a localised and permanent dilation of a blood vessel. An abdominal aortic 
aneurysm (AAA) is a particularly prevalent type of aneurysm located in the descending aorta 
between the diaphragm and the kidneys. The criterion for classification as an AAA is a 
diameter over 150% of the normal vessel size, or an absolute diameter greater than 3cm [1], 
[2]. Most AAAs are spindle shaped, however, some can form asymmetric bulges on one side 
of the vessel – these are called fusiform and saccular aneurysms respectively [3]. Over 75% 
of aneurysms will also contain layers of clotted blood attached to the vascular endothelium 
known as intra-Luminal thromboses (ILTs) [4]. When one speaks of an aneurysm, the 
combination of the thrombosis and dilated blood vessel is implied, as the two components 
affect one another and can both lead to various pathologies [5]. Figure 1 shows the aneurysm 
vessel wall in grey and the thrombus in red and green.  
 
 
Figure 1- Restructured geometry of an AAA (white) containing an ILT (red and green) reconstructed from CT 
scan imagery [6] 
1.1.2 Risk Factors 
In Southern Africa the prevalence of AAAs was estimated to be 0.2% of the total population in 
2010, a slight increase from the years earlier at 0.19%. Australasia showed the highest 
prevalence at 0.31% [1]. These fairly low prevalence numbers hide the fact that thrombosis 
and aneurysm related pathologies are one of the leading causes of immediate death globally, 
disproportionately affecting the elderly and male population [2]. To illustrate the magnitude of 
this variation, the global prevalence of aneurysms in individuals above the age of 80 is 3% [1], 
and 5 times more prevalent in males than females [7]. Nevertheless, the risk of rupture can 
Page 2 
 
be four times higher for women than for men [8], so mortality rates are roughly equal for both 
genders. Quantity and duration of cigarette smoking showed significant correlation with risk of 
AAA, whereas regular consumption of fruits, vegetables, nuts and fish was correlated with 
slightly lower risk. Family history of aneurysms was also identified as a significant predictor of 
risk, as was high blood pressure and obesity to a lesser extent  [7]. Atherosclerosis has been 
thought to lead to thrombosis and aneurysms, however, this idea has recently been challenged 
by observations that AAA can develop in blood vessels free of plaque [3]. 
1.1.3 Diagnosis and Risk Metrics  
Most aneurysms will gradually grow while causing no noticeable symptoms or effects until 
such time as they suddenly rupture [2]. If rupture occurs away from a hospital, the mortality 
rate is up to 90% [1], and just less than 50% if it occurs in a hospital [7]. Early diagnosis and 
treatment are vital to curb mortality and morbidity rates associated with unexpected rupture. 
Fortunately AAAs can be identified non-invasively with high accuracy and fairly low cost by 
means of ultrasound imaging [7]. Size is often used as a rule of thumb by clinicians, with 5 or 
5.5 cm diameter typically the threshold above which surgical intervention is deemed absolutely 
necessary [9]. This approach is unreliable though, as small aneurysms have been known to 
rupture and large ones to remain asymptomatic for years [5], [9]. This has led clinicians to 
seek better metrics to inform the decision to intervene or not. 
 
Aneurysm growth rate is one such metric, as there is empirical evidence that a faster growth 
rate correlates with a higher risk of rupture [10]. However, identifying growth rate is only 
possible in cases where a patient can be closely monitored, which typically involves an 
ultrasound or CT scan every 3 to 6 months [11]. This is not possible if the aneurysm is already 
at high risk of rupture when it is identified, nor is it feasible if the patient lacks access to 
qualified diagnosticians for practical or financial reasons [9]. Nevertheless, if it is possible, it 
has been shown that regular monitoring of stable AAAs smaller than 5.5cm diameter is safe 
and preferable to premature surgery [8]. 
 
A promising biochemical indicator for risk of rupture is the level of serum MMP-9 in the blood 
[8]. This substance is involved in the degradation of the aortic wall, so some studies suggest 
that elevated levels not only indicate the presence of an AAA, but the quantity of MMP-9 can 
be correlated with the size and expansion rate of these aneurysms [12], [13]. Subsequent 
studies have found no correlation between AAAs and MMP-9 and have called into question 
their diagnostic use [14].   
 
A more accurate and certain method for risk analysis would clearly be beneficial. To this end, 
many studies have sought to tackle the problem explicitly by simulating the relevant 
physiological features by means of computational modelling. The fundamental assumption is 
that rupture occurs when the tensile stresses in the vessel wall exceed the strength of the 
tissue. This approach is not as simple as it sounds though, as wall strength can vary 
significantly between patients and within the aneurysm itself [3], [15]. The wall stress is also 
subject to spatio-temporal variation due to blood pressure, flow structures and the shielding 
effect of the thrombus on the wall [4], [5], [16]. Nevertheless, where simulations have 
attempted to quantify wall stress, a strong correlation has been found between risk of rupture 




Despite the potential accuracy of wall stress simulations for prediction of rupture risk, the 
complexity and computational requirements of this method makes it impractical as a diagnostic 
tool at present. The majority of clinicians continue to use maximal diameter, growth rate, and 
various other empirical or related diagnostic markers to build up a composite risk profile [8]. 
The decision tree currently in use by clinicians can be represented as follows:  
 
 
Figure 2 - Treatment decision tree for AAA prior to rupture [8] 
1.1.4 Treatment Options and Success Rates 
The only effective means of preventing aneurysm rupture at present is invasive surgery [2]. 
Given that patients are usually of advanced age and potentially in poor health, this surgery 
does carry some risks. Post-operative complications can include renal failure, paralysis and 
cardiac or pulmonary ischemia [18]. Non-invasive treatments such as statins or doxycycline 
have shown potential for preventing aneurysm growth but these are still in research phase [8]. 
Surgical procedures fall into two categories: open surgery or endovascular repair (EVAR). 
 
Open surgery requires the patient to be under general anaesthetic, and usually involves a 
midline laparotomy and cross-clamping of the aorta [19]. As illustrated in Figure 3, A synthetic 
textile vascular graft is placed within the diseased section of the aorta and sutured in place. 
The vessel is then closed around the graft with the intention that the graft will relieve pressure 




Figure 3- Diagram of open surgical repair of AAA[20] 
EVAR is significantly less invasive and better tolerated than open surgery so it has been 
gaining popularity since it was introduced in the early 1990s [18]. Small incisions are made in 
the groin and an endograft or stent along with its placement mechanism is pushed upstream 
through the arteries until it reaches the correct position in the aorta. The graft or stent is 
expanded to fix it in place and the introducer mechanism is removed. Only 40% - 80% of AAAs 
are amenable to EVAR, with difficulty usually arising from insufficient attachment region 





Figure 4- Diagram of endovascular repair for AAA[20] 
Various studies have been conducted on the comparative effectiveness and risks of open 
surgery vs EVAR. EVAR typically has significantly lower 30-day mortality rates than open 
surgery. Two large European studies have found 1.7% [19] and 1.8% [8] mortality for EVAR 
compared to 4.7% [19] and 2.7% [8] for open surgery. However, long term success of EVAR 
is worse than open surgery, with at least 25% of patients requiring subsequent interventions 
or open surgery to rectify complications [19]. Various European studies have shown that the 
failure rate for endovascular repair is 3% per year (1% by rupture and 2% by a required 
conversion to open repair) versus a failure rate of 0.3% for open repair. Two years after 
endovascular repair, 6.1% of patients with large AAAs died from aneurysm-related causes 
and 8.2% needed conversion to open repair [8].  
 
While these percentages are revealing about the performance of surgical interventions, they 
are based on European figures. In the South African context, high rates of HIV and 
Tuberculosis can lead to a higher proportion of ‘high risk’ cases. In a recent study at Groote 
Schuur hospital in Cape Town the 30-day mortality rate after all elective AAA repair was 5.1% 
[18]. 
1.2 Biological Context 
1.2.1 Blood Vessels 
Blood vessels are complex structures which must respond and adapt constantly in order to 
facilitate the healthy distribution of blood in the body. Blood vessels will dilate or constrict 
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quickly in response to changes in temperature or injury, and on a longer timescale they can 
become thicker or thinner in response to stresses caused by blood pressure [21]. The large 
arteries have an additional function of assisting the work of the heart by expanding elastically 
during systole - thus reducing the peak pressure seen by downstream vasculature and organs 
- then recoiling during diastole to maintain arterial pressure while the heart is refilling [22].  
 
The blood vessels are able to perform these functions because of the structure of the vessel 
wall. Arteries are typically more thick, muscular and elastic than veins and do not contain 
valves. The vessel wall of a large artery is made up of three layers as shown in Figure 5, the 
tunica intima or interna, tunica media and tunica adventitia or externa. The intimal layer is 
made up of a single layer of endothelial cells surrounded by a thin membrane of elastic 
connective tissue. The medial layer contains smooth muscle cells and bundles of elastin and 
collagen fibres. The external layer consists of another elastic membrane and a network of 




Figure 5- Structure of the aorta wall [23] 
 
If the artery wall stiffens or loses its elasticity, either as a result of atherosclerotic plaque or a 
degradation of the elastic fibres, the pressure pulses from the heart will propagate faster and 
have higher peak values [3], [21]. Studies have shown that the medial layers of aortic 
aneurysms contain less collagen and elastin than the neighbouring healthy aorta, resulting in 
a decrease in extensibility [9], [24]. It is not clear whether this degradation is the cause or 




The Aorta exits the left ventricle of the heart vertically and is known as the ascending aorta 
until it turns downward at the aortic arch. The descending aorta travels down through the torso 
until it splits near the pelvis to become the left and right iliac arteries. Within the descending 
aorta the length above the diaphragm is known as the thoracic aorta, and the section between 
the diaphragm and the split to iliac arteries is called the abdominal aorta (AA). The AA is one 
of the most common sites for aneurysms, the reason for this is still the subject of research. 
Wills et al. [25] suggested that the AA below the renal arteries (known as the infrarenal aorta) 
is especially prone to aneurysms because the vessel tapers and becomes less elastic. This 
change in the structure of the aorta is thought to create higher pressure peaks which then 
damage the vessel wall. Taylor & Draney [21] suggested that the multiple bends, bulges and 
branches of the AA create complex and recirculating flow as well as reflected pressure waves 
which travel up towards the heart and interfere with those travelling downwards.  
 
In many AAAs, the flowing blood is not in direct contact with the aorta wall due to the presence 
of intra-luminal thromboses (ILTs). Typically, these ILTs will form in the bulge created by the 
aneurysm, gradually filling all the additional space but not encroaching far into the mainstream 
of blood flow. It is common to observe an ILT surrounding an area of free-flowing blood which 
is a similar diameter and shape to the original blood vessel. This region of free flow is called 
the lumen [2], [4] and can be seen as a white circle surrounded by grey thrombus in Figure 6. 
The effect of ILT on AAA growth, wall stress and rupture is not well understood, however the 
ILT is thought to have a significant biochemical and haemodynamic effect on the relationship 
between the blood and the vessel wall. It has been shown that ILT destroys endothelial and 
medial cells by means of hypoxia, leading to further degradation of the vessel wall and blocked 
transfer of vasoconstrictors and vasodilators [3], [5], [26]. ILT could also alter the stress 
distribution on the vessel wall, potentially shielding it from peak direct and shear stresses [27]. 
 
 
Figure 6 - Axial CT scan of 8cm AAA with lumen indicated [28] 
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1.2.2 What is Blood? 
Blood is a combination of various constituents, all with their own specific behaviours and 
influences on the whole. These constituents are most commonly described as plasma, white 
blood cells, red blood cells, and platelets. While these four account for the majority of the blood 
volume, there is a fifth category which plays a major role in the study of thrombosis. This is 
the microscopic enzymes and proteins which permeate the entire circulatory system, albeit in 
tiny concentrations. When all of these constituents are in place, the fluid is called whole blood, 
that is, the substance which fills the vessels of any healthy person. To simplify research 
questions, some of these constituents are removed, isolated or changed.  
1.2.2.1 Plasma 
Blood plasma can be isolated to form a clear yellowish fluid containing the proteins and 
enzymes. This is useful for investigating coagulation effects without the influence of the larger 
blood cells, and allows the use of particle image velocimetry (PIV) - a method for accurately 
measuring the velocity of a clear fluid using suspended micro-particles and rapid photography 
[29]. When plasma is used in experiments without the reintroduction of platelets or other blood 
cells, it is called platelet free plasma (PFP) or platelet poor plasma (PPP). If platelets are 
reintroduced to the plasma, it becomes platelet-rich plasma (PRP). This substance is useful 
for in-vitro coagulation experiments, as the interaction of flow, platelets and enzymes is 
sufficient to generate thromboses [29]. 
1.2.2.2 White Blood Cells 
White blood cells play a minor role in the physical and chemical mechanisms of thrombosis. 
Typically, passing cells will be caught in the fibrin mesh or gel and thus form some of the bulk 
of the clot. While their presence is vital for preventing infection when there has been injury to 
the vessel and exposure to an external environment, they may be unwelcome in aneurysm 
ILTs where the vascular wall is weakened but still intact. Some studies claim that these white 
blood cells create inflammatory enzymes which will lead to further degradation of the vascular 
wall, thus increasing the volume of the aneurysm bulge or even leading to rupture [3], [30].  
1.2.2.3 Coagulation Enzymes 
Blood enzymes can be isolated from plasma in order to investigate their effects individually, 
however, this is technically challenging. Pure samples of relevant coagulation enzymes are 
difficult to obtain, therefore the more common approach in experimental work is to inactivate 
certain enzymes. Corn trypsin inhibitor is used to inactivate coagulation factor XII [31], and 
snake venom is used to prevent the formation of fibrin [32]. 
1.2.2.4 Red Blood Cells 
Red blood cells (RBCs) or erythrocytes are large biconcave cells which are responsible for 
the colour and opacity of blood. They play a passive yet significant role in coagulation. Firstly, 
they have phospholipid membranes which provide a surface upon which many of the 
coagulation reactions can take place [33], [34]. Secondly, the proportion of red blood cells 
(known as haematocrit) in the whole blood has been shown to affect the size and shape of the 
final thrombus [35]. This could be due to RBCs increasing blood viscosity, hence altering the 
haemodynamic environment. Higher viscosity would lead to longer residence time for 
thrombotic agents and promote faster clotting [33]. An alternate explanation is that passing 
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RBCs are often trapped by the clot and incorporated into its mass, thus more RBCs moving 
past the clot would lead to more entrapment. Finally, the RBCs exhibit visco-elastic behaviour, 
so their presence in the thrombus could have an effect on its mechanical properties. Densely 
packed and compressed RBCs in ILTs have been linked to greater resistance to thrombolysis 
[34].  
1.2.2.5 Platelets 
Platelets are small blood cells which play a vital role in coagulation. They are created in the 
bone marrow by the fragmentation of larger cells called megakaryocytes and typically last in 
the blood for 8-10 days [36]. They are typically 6μm3 in size and occupy about 3% of blood by 
volume [37], [38]. 
 
Platelets are usually in an inactive state in which they are flat and largely inadhesive; this 
allows them to circulate freely in the blood without causing undue coagulation. However, under 
certain conditions platelets are stimulated to activate. Once this happens, the cells change 
their shape and membrane properties in order to adhere better to each other and the damaged 
cell wall. This results in the aggregation of platelets which form the bulk of the thrombus 
volume [37]. Platelets also play an important role in the biochemical reactions which regulate 
haemostasis by providing a surface on which reactions can occur [39]. 
 
1.3 Theories of Thrombogenesis 
What causes a healthy blood vessel to enlarge into an aneurysm is still unknown. While it is 
possible to observe the mechanisms associated with enlargement, it is still unknown what 
initiates this pathology. The same could be said of the intraluminal thrombus. The growth and 
maturation of the thrombus is better understood than the causes of its initiation. In the case of 
trauma leading to vascular dissection, the initiating cause is obvious, for example a cut from 
a knife which breaks the vascular wall. In that case the sudden interaction of flowing blood 
with subendothelial substances such as tissue factor (TF), von Willebrand factor (vWF) and 
collagen initiates coagulation through mechanisms common to thrombosis and haemostasis. 
In the case of ILT in AAA, the blood vessel is merely distorted not dissected. Flowing blood 
should have no contact with subendothelial substances and yet clotting still occurs. Some 
studies have shown that the endothelium and blood cells do generate TF [40], [41], though 
the relative significance of these two sources is still the subject of research.  
 
The expression of von Willebrand factor at the endothelium is another potential contributor to 
thrombogenesis in AAA, however, murine experiments showed that ILTs can still develop -
albeit at a reduced rate - in the absence of vWF [36]. What is clear is that vascular tissue in 
an aneurysm becomes more prone to platelet adhesion and thrombogenesis than surrounding 
healthy aortic tissue [42].  
1.4 Platelet Activation and Adhesion 
As mentioned earlier, platelets are continuously present in healthy human blood. Their role is 
to remain in solution in the flowing blood until such time as they are recruited to form a clot, 
then to play various important roles in the clotting process. In the case of vessel dissection, 
the first role of platelets is to form a ‘platelet plug’ at the site of haemorrhage in order to slow 
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down and block escaping blood flow. In the case of ILTs, the ‘plug’ metaphor is not applicable 
to this mechanism; rather, the first stage is called ‘adhesion’ where platelets stick to the 
endothelium.  
 
Initial adhesion occurs as a result of vWF molecules bonding to collagen in the vessel wall 
and receptors on the platelet membrane. The most significant initial bond is between vWF and 
a glycoprotein called GP1b in the platelet membrane. This glycoprotein is receptive to vWF 
bonding even when platelets are inactive, so as passing platelets bump into a thrombogenic 
section of blood vessel, they can be slowed, arrested and held in place [36], [42], [43]. Von 
Willebrand factor will also cause cross-linking between platelets by bonding GP1b and various 
other membrane-based glycoproteins together [44], [45]. These bonds between inactive 
platelets and the vessel wall are considered weak, and are likely to be broken in the high shear 
environment of the abdominal aorta [43].  
 
This implies that reduced wall shear stress is a necessary precursor to ILT formation, thus 
creating a tantalising link between the haemodynamic environment created by the unusual 
aneurysm geometry and the propensity for localised intraluminal thrombosis. Many studies 
have sought to demonstrate a connection between thrombosis growth and haemodynamic 
conditions [2], [4], [46]–[50]. Unfortunately, the results are often contradictory, validation 
samples small, and modelling assumptions diverse. Studies also vary in how they define shear 
stress. Some calculate maximal systolic wall shear stress, others time-averaged wall shear 
stress over multiple heart beats, and yet others use oscillatory shear index, a measure of the 
changes in shear direction. Nevertheless, the research points towards a spatial correlation 
between low shear stress at the vessel wall and higher likelihood of ILT growth. Some studies 
even proposed a maximal threshold or bounded range of shear within which conditions are 
just right for thrombosis [2], [47].   
 
It would be a mistake, however, to simply associate low shear stress to high thrombotic 
potential. The reality is that high shear stress in the blood can have a pro-thrombotic effect by 
means of platelet activation. Shear stress is sufficient to activate platelets even in the absence 
of chemical agonists [51]. The activation appears to correspond with cumulative damage to 
the platelet membrane as a result of dynamic and oscillatory shear stresses. This is of 
particular importance where the geometry of implanted medical devices such as stents or 
valves creates regions of ultra-high stress leading to increased thrombosis risk at the site of 
the implant [52].  
 
A potent biochemical activator of platelets is thrombin. Thrombin is generated by a series of 
chemical reactions described later, but given that these reactions are initiated at a 
thrombogenic surface, thrombin is primarily present near the site of thrombosis. When 
thrombin comes into contact with protease-activated receptors (PARs) on the membrane of 
the platelet, it activates the platelet. Other dissolved substances such as adenosine 
diphosphate (ADP) and Thromboxane A2 (TxA2) are weak platelet activators [51], [53]. 
 
When platelets are activated, more glycoprotein receptors on the cellular membrane become 
receptive to bonding, most notably the GPIIb receptor. This receptor, once activated, will 
readily bond with vWF and fibrinogen [42]. Fibrinogen is a dipolar molecule which is plentiful 
in the blood. When each pole of fibrinogen attaches to the GPIIb receptor on neighbouring 
platelets, a strong and permanent bond is created [54]. This leads to two effects - firstly, 
platelets which were initially trapped by weak vWF-GPIb bonds will consolidate to form a 
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stronger network as platelets become activated; and secondly, passing platelets are more 
likely to adhere to the fledgling clot if they are already activated. The result is that activation of 
platelets at the vessel wall or in the blood represents a powerful mechanism to increase the 
strength and growth rate of the clot after the initial adhesion. The phase wherein platelets are 
activated and form permanent bonds together is called aggregation [45].   
 
The observation that platelets are prone to activation in regions of high shear but more likely 
to adhere to the vessel wall in regions of low shear, has led researchers to suggest that 
platelets play a large role in the site and shape of thrombus growth. The theory is that the 
irregular geometry of the proximal (upstream) end of the aneurysm creates turbulent flow in 
which shear stresses on fluid particles are elevated and platelets are activated. Once platelets 
are activated, they are either carried away with the bloodstream or become attached to the 
aneurysmal endothelium in areas of low shear [3]. Given that activation by shear is not 
instantaneous, one would expect to see  greater aggregation of platelets in the distal part of 
the AAA, and indeed clinical observations do show this [47].  
1.5 The Coagulation Cascade 
 
 




The coagulation cascade is a series of chemical reactions which ultimately produce thrombin. 
Thrombin has the capacity to activate platelets as mentioned before, but in addition to that, it 
catalyses the formation of fibrin from fibrinogen and interacts with other pro- and anticoagulant 
enzymes to modulate the thrombotic response. Given that slow or insufficient coagulant 
response would lead to haemorrhage, and overactive response could lead to vessel occlusion, 
it is vital that the coagulation system be tightly controlled. This goes some way to explain why 
the coagulation cascade is such a complex system of inter-related reactions. Another 
important feature of the coagulation cascade is gearing or amplification. This means that 
initiation by a small quantity of one enzyme can catalyse the creation of a larger quantity of 
the next enzyme which in turn catalyses a yet larger quantity of the next enzyme. The result 
is that a small initiating stimulus can lead to a rapid increase in thrombin. This process is 
typically broken down into three stages: initiation, amplification, propagation [56], [57] 
1.5.1 Initiation 
 The initiation of the coagulation cascade starts with tissue factor. Tissue factor is present in 
the medial and adventitial layers of the blood vessel and has been shown to exist in blood 
cells and microparticles too. This so-called blood borne tissue factor may contribute to the 
initiation of ILT, however, at this stage it is not known to what degree [39], [40]. In the case of 
aneurysms, the endothelium is compromised to the point that vascular TF comes into contact 
with the blood. Tissue factor combines with activated factor VII in the blood to create the TF-
VIIa complex. This complex reacts with other proteins to produce thrombin. This process is 
known as the extrinsic pathway and is described in more detail by Mackman et al. [40]. The 
extrinsic pathway is important for creating the first expression of thrombin, however, this 
thrombin in turn activates the intrinsic pathway which gradually takes over during the 
amplification phase.  
1.5.2 Amplification and Propagation 
As more platelets become activated the rate of thrombin generation and the quantity of 
thrombin increase rapidly [58]. This is due to a positive feedback loop where thrombin 
activates enzymes V and VIII which, in turn, promote the production of more thrombin. Over 
95% of total thrombin production occurs due to the intrinsic pathway [56], however, there is 
still interaction both ways between the two processes [37]. Enzymes such as antithrombin and 
tissue factor pathway inhibitor (TFPI) will act to suppress the amplification of thrombin 
production, and the myriad of reactions between the many agonists and antagonists creates 
a dynamic and complex system which will not be described exhaustively.  
 
An interesting feature of this system is that the region of peak thrombin generation begins at 
the vessel wall, but can move towards the centre of the blood vessel by means of a process 
called propagation. This is not to be confused with the natural advection and diffusion of a 
chemical species away from its source of origin - rather, the blood has been likened to an 
excitable medium, where catalysing enzymes will cause the blood in the bulk fluid domain (as 
opposed to the platelet plug region) to generate thrombin. This region of excitation can be 
thought of as a wave, which starts at the endothelium and moves into the fluid with an 






Figure 8 - Propagation of thrombin in blood plasma based on TF stimulation [32] 
The propagating wave observation was shown in plasma where fibrin formation was blocked 
by the addition of snake venom and platelets were not present - hence no clot could form. 
Where a porous thrombus has formed over the endothelium the situation becomes slightly 
more complex. Proteins are macromolecules which can be hindered in their movement 
through the thrombus by the dense packing of cells and fibrin. Solute transport from the flowing 
blood into the centre of the thrombus and vice versa is hindered. Thrombin is generated by 
the interaction of prothrombin and prothrombinase, however, these two enzymes are primarily 
present in the fresh blood flow and thrombus core respectively. Only the region where both 
enzymes are present will generate thrombin, but as the clot grows in size and hindrance, that 
region will narrow and perhaps vanish. This mechanism may be a reason for the slowing or 
cessation of thrombus growth, however, although this has not yet been demonstrated 
conclusively [34], [60]. 
1.5.3 Decay        
In stagnant blood where thrombin generation is initiated by any mechanism, the thrombin 
concentration can be seen to rise and then fall over time. The rise in thrombin levels can be 
explained by the dominance of procoagulant reactions, and conversely, as the thrombin levels 
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fall, the anticoagulant reactions dominate to slow and ultimately cease thrombin production. 
This process is known as decay. The key substances which act as antagonists to thrombin 
generation are thrombomodulin and anti-thrombin. Thrombomodulin interferes with factors V 
and VIII, which are key to maintaining the intrinsic pathway. Antithrombin reacts with factors 
IXa and Xa to further suppress the production of thrombin by either pathway. In addition, 
antithrombin reacts with thrombin directly to neutralise it permanently  [58]. 
 
The relative concentrations, efficacies and reaction rates of the procoagulant and 
anticoagulant substances can vary significantly between individuals, and can be severely out 
of balance in patients with haemophilia. In patients with aneurysms and thrombosis, the 
coagulation potential of a patient’s blood is of great interest for both diagnosis and treatment. 
Various methods have been used in the past, however, pioneering work by Hemker et al. has 
led to the wide use of a test called the Calibrated Automatic Thrombogram. This test will be 
described in more detail later [61], [62]. 
1.6 Fibrin Generation, Morphology and Properties 
The primary purpose of thrombin is to act as a catalyst for the conversion of fibrinogen to fibrin. 
Fibrinogen is a glycoprotein which is synthesised in the liver and circulates in the blood at fairly 
high concentrations compared to the proteins mentioned previously. In the presence of 
thrombin, fibrinogen molecules will be activated and become a fibrin monomer. These 
monomers will readily bond with each other to form long polymer chains known as fibrin 
strands. When these fibrin strands form over and between the agglomeration of platelets and 
blood cells, the result is a highly resilient composite - much like ropes tying down luggage on 
a trailer [43]. The powerful effect of fibrin on a clot is demonstrated in an experiment by Brass 
and Diamond. It was found that platelet deposits lacking fibrin could withstand maximal wall 
shear rates up to 5300 s−1 (159 dyne cm−2 wall shear stress), while a thrombus made of a 
combination of platelets and fibrin could withstand up to 83 000 s−1 (2500 dyne cm−2) before 
embolization [63].   
 
The relationship between fibrin and platelets is an interconnected one. The initial platelet plug 
creates a porous zone which acts like pebbles in a stream. Fluid velocities between the 
platelets are significantly lower than the flowing blood in the main stream [43], [63]. This 
quiescent zone provides sufficient residence time for blood-borne substances to react and 
form fibrin [50]. Aneurysms or deformations in the endothelium can create eddies and low 
velocity zones which may also create the conditions in which fibrin can form [41]. This 
protective effect of platelets is especially important in large arteries where flow velocity is at 
its highest. Without the protection of platelets it would be impossible for a fibrin mesh to form 
[64].  
 
A study of fibrin formation in platelet free plasma at a microfluidic scale shed light on some of 
the key haemodynamic and biochemical factors which affect fibrin morphology [41]. The 
results show significant qualitative differences in the appearance of fibrin deposits when shear 
rate, thrombin concentration, and supply of fibrinogen are varied. The morphologies are 
classified as thin film, dense mat, or fibrous gel. What was notable was that the thickness of 
the fibrin strands themselves and the degree of cross linking between them varied greatly. At 





Figure 9- Effect of shear rate on fibrin morphology. Dark dots represent pores in membrane [41] 
 
Figure 10 - Effect of thrombin flux on fibrin morphology. Dark dots represent pores in membrane [41] 
Another study on this topic found that “low thrombin concentrations produce fibrin clots that 
are turbid and composed of thick, loosely-woven fibrin strands. Higher concentrations of 






Figure 11 - Effect of thrombin concentration on fibrin morphology [65] 
An experiment which sought to account for the haemodynamic effects of platelets on fibrin 
production used microscopic beads as a means of reducing convection rates or ‘washout’ of 
coagulation agonists [50]. The study posited that TF‐coated silica beads can support 
coagulation in a way that is comparable to platelets for the purpose of this experiment. Platelet 
free plasma with supplemental fibrinogen was used, but unlike the previous study, no thrombin 
was introduced to the fluid. Instead, the tissue factor on the silica beads initiated the 
coagulation cascade resulting in the production of thrombin and then fibrin, and both of these 
substances were monitored over time in the experiment.  
 
 




Shear rates were varied between 50s-1 and 1000s-1 showing that as shear rate increases, 
thrombin concentration and fibrin density are reduced. At shear rates above 500s-1 both 
substances are present in such small quantities as to be practically insignificant. When shear 
rates were low enough to allow a fibrin gel to form, it was observed that fibrin growth rate and 
maximum size of clot increased as shear rate dropped, and also increased with the initial 
concentration of tissue factor on the silica beads. Thrombin density showed a similar response 
to these two variables - with negligible or low production at 0.08 molecules TF per µm², 
delayed production at 0.8 molecules/µm² and rapid production at 8 molecules/µm². This shows 
that the quantity of tissue factor available at the initiation of the coagulation process will have 
a proportional knock-on effect to the rate and quantity of the final products of the entire 
chemical cascade. Despite this dependence  on tissue factor, the effect of shear rate was 
shown to be of greater impact on fibrin growth. 
 
 
Figure 13 - Effect of shear rate on fibrin diameter, orientation and height [50] 
A final point to mention about the morphology of fibrin is cross-linking between fibrin polymer 
chains. This is a feature of many other types of polymer and has a similar effect. Cross links 
increase the strength of the polymer and create a more three-dimensional matrix of bonds. 
The effect of cross-linking is a stronger fibrin mesh, and ultimately a more stable thrombus. 
Cross-linking is promoted by factor XIII which is present in the blood and is activated by 
thrombin [45], [66].  
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1.7 Thrombus Growth and Cessation 
Many patients live with aneurysms which contain intraluminal thromboses for years with no ill 
effects. In these cases, the thrombus is either growing at a rate which can only be observed 
over long periods, typically measured in the order of mm per month, or has stopped growing 
completely. Some ILTs grow far more rapidly, often immediately after a surgical procedure, 
leading to severe complications or mortality. Full vessel occlusion or embolization has been 
observed one day [67] and even a few hours [68] after surgery for coronary artery repair. This 
shows that ILT growth rate is highly variable, and highly significant to predicting and managing 
the effects of AAAs before and after surgery. It is therefore of great clinical interest to 
understand the mechanisms which influence growth rate. 
 
Many attempts have been made to correlate haemodynamic variables such as time-averaged 
wall shear stress (TAWSS), oscillatory shear index (OSI), and relative residence time (RRT) 





Figure 14 - Plots of haemodynamic variables and ILT growth rate for patients with significant thrombus deposition 
[69] 
Figure 14 shows that haemodynamic variables may be of use in predicting slow ILT growth in 
some cases, but not all. As for rapid ILT growth, the type that occurs in a few hours, very little 
information exists on the causes and frequency of this phenomenon. Given the widespread 
application of vascular surgery (both open and endovascular), and the growing possibilities 
Page 20 
 
for other types of endovascular implants, it would be of great value to develop tools to predict 
likelihood and severity of rapid thrombus growth. 
 
Cessation is another aspect of thrombosis where research could lead directly to improvements 
in diagnosis, management and treatment. Cessation can be defined broadly as a growth rate 
approaching zero for a significant period without surgical intervention. There are multiple 
factors which appear to contribute to this phenomenon, and these will be discussed below. 
 
As mentioned previously, one proposed mechanism for cessation is based on the region in 
which thrombin can be produced. The proposition by Kattula et al. [34] was that prothrombin 
(the precursor to thrombin), which is present in the blood, has limited access to 
prothrombinase (a catalyst generated by both the intrinsic and extrinsic coagulation 
cascades), which is generated on phospholipid membranes within the thrombus. If transport 
of either of these substances is hindered by distance, densely packed cells, reduced diffusivity, 
or washout due to advection so that they cannot react and create thrombin, then cessation will 
likely be the result. 
  
Another theory of cessation is based on the interaction between the blood flow and the 
platelets on the surface of the thrombus. It has been demonstrated that platelets can adhere 
to the thrombus only when shear stress at the surface is below a critical value. If the shear 
stress exceeds this value, the platelets will either not attach at all, or will attach momentarily 
then break off in chunks [70]. Initially the ILT tends to form in a region of low flow velocity 
where stresses are low. However, as the clot grows away from the vessel wall it can encounter 
more rapidly flowing blood, and thus experience higher shear stress at its surface. If the shear 
stress over parts of the surface of the thrombus exceeds the critical value, then platelet 
adhesion is unlikely, and existing platelets may be removed to expose the fibrin network below. 
This fibrin mesh can resist much higher shear stresses so this layer will remain as the outer 
layer of the thrombus until such time as the haemodynamic environment changes or the fibrin 
is broken down by biochemical processes [43], [64]. 
 
Another suggestion for a mechanism of clot cessation is based on the location and movement 
of thrombin within the thrombus. As mentioned previously, platelets can adhere to the 
thrombus surface weakly when they are inactive, but more strongly when they are activated 
[43]. Thrombin is a potent platelet activator, and if it is present at the surface of the thrombus 
then platelets are more likely to be activated and adhere to the thrombus permanently. 
However, if the surface of the thrombus is primarily fibrin - known as a fibrin cap - thrombin 
will only be generated deeper within the thrombus where tissue factor and phospholipid 
membranes are more abundant. The thrombin generated in the clot core may be washed 
downstream by intra-thrombus flow before it can reach the thrombus boundary. The effect of 
this is that platelets on or near the surface of the clot will be separated from the regions of high 
thrombin by the fibrin cap. Without thrombin, these platelets are not likely to become activated 
nor adhere to the thrombus. The conclusion is that a thick fibrin cap may contribute to 
cessation of clot growth [71]. 
1.8 Thrombus Composition 
Clot composition has been shown to vary as the thrombus matures, and differences in 
haemodynamic and biochemical environments will likely cause significant differences between 
patients. Information of patient specific clot composition is not easily obtainable in-vivo, 
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however, post-operative or post-mortem analysis of thromboses can give detailed information. 
The typical thrombosis constituents based on averages of many such analyses are shown in 
Table 1 below. 
Table 1 - Average composition of ILTs 
Fibrin Platelets Erythrocytes Leucocytes Reference 
49.1 % 11.6 % 24.2 % 3.7 % Sadowski [72] 
55.9 ± 18 % 16.8 ± 18 % 11.5 ± 9 % 1.3 ± 2.0 % Silvain [73] 
1.9 Computational Models 
Computational modelling of thrombosis and aneurysms in the past would focus on one aspect 
of the physiology - such as wall shear stress or tissue factor concentration - in order to draw 
some conclusions about the overall pathology. With increased hardware capacity and 
advancing knowledge, the trend has moved more towards integrated approaches which aim 
to capture as many of the chemical and mechanical intricacies as possible in one model. The 
following section will attempt to describe the key areas of interest and development in the field 
of aneurysm and thrombosis modelling, with reference to a wide range of experimental and 
computational work. The goal of this summary is to learn from the best techniques used by 
others, with a view to incorporating these techniques into a new model.  
1.9.1 Modelling of Blood 
The overwhelming majority of studies treat blood - or at least part of the blood - as a flowing 
continuum which can be described by the Navier-Stokes equations for incompressible fluids. 
In recent years there has been a move to more accurately represent the interactions between 
blood cells such as RBCs and platelets by modelling them as discrete particles or small 
volumes. This approach has the potential to represent physiological clotting and flow with great 
accuracy, as many of the key features of clotting take place due to the interactions between, 
or evolution of, individual blood cells or particles. For example, the Lagrangian approach to 
following a platelet as it enters the flow region would allow one to track the shear stress on the 
particle over time - thus predicting if that platelet becomes activated, adhered, or eroded from 
the clot surface [74].  
 
While the discrete particle/volume approach is appealing for its potential accuracy, the 
computational costs are often prohibitively high [64]. Many studies have chosen to use a 
completely Eulerian approach and treat the various species in the blood as massless scalar 
quantities which are generated in certain regions or boundaries, react according to various 
rules inherent to the model, move due to advection within the fluid, and diffuse according to 
either the standard mechanism of Brownian motion or according to more complex diffusion 
models. These features, or partial combinations of them, are usually called CDR models, an 
acronym for Convection, Diffusion & Reaction. An exciting development in thrombosis 





In a recent example [43], blood proteins such as fibrin and thrombin were calculated using an 
Eulerian CDR approach while plasma and platelets were treated as small Lagrangian volumes 
in the flowing medium. Platelets could be active or inactive, and a mechanism for greater bond 
strength between platelets was incorporated when sufficient fibrin was present to act as mesh. 
The results showed that as the thrombus grows, the inner bulk of platelets is firmly bonded by 
fibrin, but the outer ones are not. As the thrombus grows further away from the endothelium it 
enters a higher velocity region of the flowing blood - this increases the shear rate to a point 
where the outer platelets are stripped away, exposing the strong but fairly inadhesive fibrin-
covered core. As mentioned previously, this is claimed to be a mechanism by which the 
thrombus would cease to grow. 
 
A feature of the fluid continuum modelling approach which is often mentioned in the literature 
is the question of Newtonian vs non-Newtonian properties for the fluid - be it plasma or whole 
blood. There has been some disagreement among researchers on this topic, with some [37], 
[48], [75] believing that velocity fields calculated with a Newtonian fluid will be inaccurate, and 
therefore a model such as Carreau-Yasuda must be introduced to simulate shear thinning 
effects. Other researchers have shown that there are situations where the difference between 
Newtonian and non-Newtonian simulations is negligible - in which case it is acceptable to use 
the simpler Newtonian approach [2], [38], [76], [77]. Various factors can influence the choice 
of using a Newtonian or non-Newtonian fluid model, but in most cases the decision is based 
on the scale of the blood vessel or experiment. If the flow domain and features are 
microscopic, such as simulation of capillaries or intra-thrombus convection, then non-
Newtonian is deemed necessary - but for larger vessels like the aorta with meso-scale 
thrombus modelling then Newtonian is a perfectly acceptable approach.  
1.9.2 Modelling of Coagulation Reactions 
Computational models which aim for maximum accuracy have sought to model the 
biochemical reactions of haemostasis explicitly and in great detail. There are dozens of 
enzymes, proteins, and chemicals which interact on various kinds of surfaces or in the fluid 
domain, so these models can be quite complex. As knowledge and computing power has 
increased, these models have grown to incorporate more and more features and refinements 
to generate more accurate results. A comprehensive review of these methods is beyond the 
scope of this project, however, it is necessary to talk briefly about the way in which biochemical 
reactions are typically simulated.  
 
Initial concentrations are specified for all chemicals at the beginning of the simulation. Typically 
these initial concentrations apply to the entire fluid domain, though some are spatially limited 
to a certain region or boundary. During the course of the simulation the concentrations are not 
calculated explicitly, rather the rate of change of concentration for all chemicals are calculated 
at each time step and the actual concentrations are adjusted accordingly. A typical rate of 
change equation will incorporate the effects of convection, diffusion and reaction as shown in 




= ∇(?⃗? ⋅ [𝜙]) + 𝐷 ⋅ ∇2[𝜙] + 𝑆([𝜙], [𝛾1], [𝛾2], … , [𝛾𝑛])  (1.1) 
Where:  
[𝜙] is the concentration of the enzyme or particle of interest, ?⃗? is the fluid velocity, 𝐷 is the 
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diffusion coefficient, 𝑆 is a source function and [𝛾𝑛] is the concentration of other substances in 
the fluid.  
  
The rate of change of a particular substance due to reactions is usually dependant on the 
concentration of one or more other substances in the same computational cell. The simplest 





= 𝑘1[𝛾1] + 𝑘n[𝛾n]      (1.2) 
Where:  
𝑘1 and 𝑘𝑛 are rate constants, [𝛾1] is the concentration of the subject which is changing and 
[𝛾𝑛] is the concentration of any other substance of interest in the cell.  
 
This approach is used to model the generation of coagulation chemicals in the Leiderman 
Fogelson model [78]. An alternative to this formulation which has the potential to more 
accurately capture the non-linear reaction kinetics present in coagulation reactions is called 
Michaelis-Menten kinetics. This formulation was intended to simulate the effect of a catalytic 
enzyme on the conversion of a substrate to a product - for example, the conversion of 
fibrinogen to fibrin catalysed by thrombin [37]. The reaction process with initial, intermediate 
and final state is shown in equation 1.3 below: 
 
𝐹𝑔 + 𝑇ℎ
  𝑘f  
→  [𝐹𝑔 𝑇ℎ]  
  𝑘cat  
→    𝐹𝑛 + 𝑇ℎ    (1.3) 
Where: 
𝐹𝑔 is Fibrinogen, 𝐹𝑛 is Fibrin, 𝑇ℎ is Thrombin and 𝑘𝑓 and 𝑘𝑐𝑎𝑡 are rate constants. The source 
of fibrin is no longer defined by purely linear kinetics, but according to the Michaelis-Menten 








)     (1.4) 
 
Where square brackets represent concentration. This formulation of reaction kinetics can be 
visualised as a graph of reaction rate (𝑆) to substrate concentration [𝐹𝑔] as shown in Figure 
15 below:  
 
 
Figure 15 - Diagram of Michaelis-Menten reaction kinetics [79] 
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Where Vmax is the theoretical maximum reaction rate in the presence of saturating substrate 
concentration and KM is a constant equal to the substrate concentration at which the reaction 
rate is half of Vmax.  
 
Most explicit biochemical models use a combination of the linear rate and Michaelis-Menten 
reaction kinetics to model coagulation reactions, with some including the effects of reaction 
inhibitors and some not. Some models consider the production of thrombin as the end point 
of the coagulation cascade, while others include the production of fibrin as the final step. All 
of these models make use of reaction constants such as 𝑘𝑐𝑎𝑡 and 𝐾𝑀 shown above in order 
to calculate reactions rates. These values are typically drawn from experimental work, but 
given that the product of a preceding reaction becomes the catalyst of the following one, the 
final result is highly sensitive to inaccuracies in these constants. The interdependence of the 
reactions in the coagulation cascade and the large number of variables makes explicit 
biochemical modelling a challenging approach. A simpler and more accurate method for 
representing thrombin generation in the blood would be of great benefit to thrombosis 
modelling. One such method which shows potential is the Calibrated Automated 
Thrombogram (CAT) [74]. 
1.9.3 The Calibrated Automated Thrombogram 
This test aims to quickly and accurately represent the concentration of thrombin over time for 
a specific patient using a single drop of the patient’s blood. The plot of concentration vs time 
is called the thrombin generation (TG) curve, and the shape of this curve provides a simple 
and graphical means to quantify the outcome of the many complex and competing biochemical 
reactions involving the pro- and antithrombotic substances in the blood.  
 
The test typically follows the following procedure. A sample of blood is taken from the patient 
- in some cases this blood is used whole, but in some tests erythrocytes and platelets are 
removed as they would obstruct the results. A synthetic fluorogenic or chromogenic substance 
is mixed into the sample, then thrombin production is initiated by the addition of a triggering 
agent containing tissue factor, phospholipids and calcium ions. As thrombin is generated, it 
reacts with the synthetic substrate to cleave fluorophores or chromophores. These substances 
emit light, and as thrombin concentration increases, so does the number of light-emitting 
particles. The output of light is continuously monitored, and this data is used to reconstruct a 
profile of thrombin concentration over time. The test is also conducted with a known and 
constant concentration of thrombin to calibrate the results of the blood test [61], [80]. 
 
This test has been useful in many clinical applications, for example, identifying hypocoagulant 
or hypercoagulant conditions in the blood, and for comparison studies to show the effect of 
drugs, aging or cardiovascular disease [81], [82]. Unfortunately, there is not yet consistency 
in the parameters and methods used for CAT tests, so comparison between one study and 
another is problematic. For example, the concentration of TF in the substance used to initiate 
clotting can vary from 0.5 pM/L to greater than 10 pM/L, with higher concentrations leading to 
quicker clotting times and more thrombin production [80], [82]. Standardisation is necessary 
before the CAT can have full clinical value for precise diagnosis and/or computational 
modelling. Fortunately efforts to standardise these tests are showing promise [83], so in the 
near future the CAT has the potential to act as a simple, fast, universal, patient specific and 
quantitative representation of coagulation response for clinical use, but also as a replacement 




1.9.4 Modelling of Thrombus  
1.9.4.1 Platelets 
Given the important role played by platelets in coagulation, most computational models seek 
to account for their presence in some way. 
 
Anand, Rajagopal and Rajagopal [37] treated platelets as massless substances within the 
fluid, representing their concentration by means of scalar quantities which take part in 
convection, diffusion and reactions within the fluid flow field. Platelets were split up into 
activated and resting concentrations and tracked separately. Leiderman and Fogelson [78] 
treated platelets as a single concentration, with a maximum value based on the estimated size 
and packing density of platelets in a clot. Within the platelets present, a second variable 
represented the fraction of bound or unbound platelets, and a probability function based on 
thrombin, ATP and shear rate controlled the conversion from bound to unbound. Tomaiuolo 
[84] claimed that it is not necessary to model platelets directly; altering the porosity fraction of 
computational cells is sufficient to represent a clotted region. Tosenberger [43] used a discrete 
particle approach to platelets, treating them as cylindrical particles which can bond together 
by various means and interact with the continuum fluid around them.  
1.9.4.2 Fibrin 
While some models do not model fibrin generation at all, those that do use a variety of 
methods. Xu [85] treated fibrin production rate as directly proportional to thrombin 
concentration. Tosenberger [43] modelled fibrin generation rate as directly proportional to the 
product of thrombin and fibrinogen concentration. Virag [5] treated fibrin generation as 
proportional to platelet concentration and inversely proportional to fibrin density within the clot, 
assuming that there is always sufficient supply of fibrinogen from the blood. The majority of 
models [37], [38], [86], [87] use Michaelis-Menten kinetics, with fibrinogen as the substrate, 
thrombin as the catalytic enzyme and fibrin as the product. An interesting similarity is that 
Anand [37] used a concentration of fibrin above 600 nM/L as the criterion for representing 
blood as clotted, whereas Bodnar [38] used 1000 nM/L. 
1.9.4.3 Porosity 
As mentioned in the section on platelets, Tomaiuolo [84] used porosity to represent the clot, 
claiming that this was sufficient to capture the haemodynamic effects in and around the 
thrombus. Porosity is typically represented as a number between 0 and 1, where 0 is a totally 
impermeable solid, and 1 is free flowing fluid. Computational solvers like ANSYS Fluent will 
use this fraction to reduce the effective volume of a computational cell. Momentum and mass 
is still conserved as the fluid moves through the porous zone, but as porosity reduces, the fluid 
must squeeze through a smaller volume. The result of this constriction is that the local velocity 
of the fluid tends to increase. This result is not necessarily desirable, and when this approach 
was used for this thrombosis model, higher velocity magnitudes were found within the clot 
than without. This outcome seems unlikely, and motivates for the incorporation of a viscous 
resistance or permeability term to reduce the velocity. Indeed the ANSYS Fluent user guide 
[88] recommends the incorporation of both when modelling porous zones, but more detail on 




The concept of porosity is refined further in papers by Brass and Tomaiuolo to include two 
zones within a stable thrombus, namely the core and shell [77], [84]. The core is characterised 
by higher fibrin concentrations and more densely packed platelets than the shell, so the core 
can have a porosity between 0.2 and 0.4, whereas the shell has a porosity in the range of 0.4 
to 0.7. Visualisations of these two zones within the thrombus are currently limited to diagrams, 
as CT scans and MRI both lack the sensitivity to differentiate between the variations in density 
and composition. Confocal fluorescent microscopy has been used to generate some images 
of the two zones, however, the relative size and of core and shell within a thrombus is still the 
subject of research. 
 
 
Figure 16 - Diagram of typical core and shell morphology in ILTs (left). Confocal fluorescent microscopy image of 
markers for core (blue) and shell (red) [89] 
1.9.4.4 𝑢 = −(
𝑘
𝜇
) ⋅ Δ𝑃𝑢𝑘 = 3𝐸 − 16 ⋅ (Φf −Φ0)
1.8Viscosity and Permeability 
A complete computational model of thrombosis needs to represent the effect of the thrombus 
on the haemodynamic environment and vice versa. Given that the thrombus is not a solid 
mass, some fluid will flow into and through the clotted region. The way in which this fluid flows, 
and the resistance offered by the thrombus, has been modelled in various ways. Some 
examples are described below. 
 
Anand used the Oldroyd-B formulation to model blood as a non-Newtonian fluid, so within the 
clot region they altered the properties of this model to give the effect of a more viscous fluid 
[37]. Bodnar altered viscosity as a linear function of fibrin concentration, with a maximum 
viscosity for a fully clotted region being 100 times higher than the viscosity of blood [38]. While 
altering the viscosity directly is a possibility for modelling a clot, it is more common to see the 
effect of viscous resistance modelled according to Darcy’s Law. 
 
Darcy’s Law is the fluid equivalent of Ohm's Law for electric circuits, where the flow velocity is 
current, pressure drop is potential difference, and resistance is a permeability variable (k) 









𝑢 is the superficial velocity through the porous region, 𝜇 is the dynamic viscosity, 𝑘 is the 
permeability and Δ𝑃 is the drop in pressure through the porous region. 
  
Dynamic viscosity is defined by the fluid itself, and in the case of Newtonian fluids will remain 
fixed and constant. The permeability term is defined by the environment through which the 
fluid is flowing, and represents the level of resistance that the porous zone (in this case the 
thrombus) will provide against the fluid flow. A 𝑘 value of unity represents a perfectly 
permeable fluid domain, i.e. no hindrance to flow. As 𝑘 approaches zero, permeability reduces 
and flow is hindered, i.e. higher pressure difference is required to drive the fluid at a given 
velocity. The effect of Darcy’s Law in the context of a continuum model of fluid flow is 
represented as a momentum sink in the continuity equation. The result is a set of equations 
known as the Brinkman equations, or alternatively the Navier-Stokes equations with the 
addition of a Brinkman term. 
 
Various studies have sought to find a value for the permeability of an ILT [63], [86], however, 
given the variability between the structure, age, and constituents of clots, results can vary by 
up to 5 orders of magnitude [90]. Experimental work by Muthard showed that under a constant 
pressure differential of around 21 mm-hg, permeability was dependent on fibrin concentration. 
For clots grown with an absence of fibrin, the permeability was 5.45 E−14 cm2, however, a 
thrombus containing platelets and fibrin had permeability of 2.71 E−14 cm2 [91]. Kim attempted 
to take this into account by calculating permeability as a function of the fibrin density in the 
clot according to the following relationship [71]:  
 




 Φf is the volume fraction of fibrin and Φ0 is a constant of 0.0028.  
 
Wufsus [90] took this a step further and developed a method to estimate total permeability 
based on fibrin and platelet density. The equations are too complex to reproduce here, but the 





Figure 17 - Permeability of thrombus based on platelet and fibrin volume fraction [90] 
1.9.4.5 Enzyme Diffusion 
Much experimental work has been done to discover the rate at which the coagulation enzymes 
diffuse through the blood. Tables showing the diffusion coefficients of all of the major 
substances within the coagulation cascade are readily available [75], and many coagulation 
simulations make use of these alone to model diffusion of coagulation factors within the blood 
and thrombus. 
 
There is, however, reason to believe that diffusion within the clot should not be treated in the 
same way as diffusion within blood. Coagulation proteins like thrombin are macromolecules, 
so as the clot becomes densely packed with platelets, fibrin and blood cells, the gaps or paths 
between these blockages can become small enough to hinder the movement of proteins [60], 
[77], [84]. This hindrance effect is quantified by a unitless number called tortuosity. Tortuosity 
is the fraction of the regular diffusion constant (𝐷) in a fluid over the effective diffusion constant 
(𝐷𝑒𝑓𝑓) within the hindered region. Voronov found that tortuosity is between 2 to 2.5 in clots 
from mice [63], whereas Leiderman & Fogelson treat tortuosity as a function of platelet density 
which can reach a maximum of 1000 for a dense clot [60]. 
 
The values and methods used to model hindered diffusion clearly show significant 
disagreement, nevertheless its physiological significance has been the subject of various 
studies. Leiderman & Fogelson suggested that hindered diffusion could contribute to slowing 
or cessation of late thrombus growth [60]. Tomaiuolo showed that hindered diffusion, rather 
than advection, is the dominant mechanism responsible for molecular movement within the 
thrombus [84], however, Brass showed the diffusion alone would be so slow that it would take 




In continuum models clot lysis is typically approached from two directions. Firstly, there is 
biochemical fibrinolysis as a result of plasmin, a reaction that can be modelled in ways very 
similar to the coagulation cascade. Some fairly recent studies ignore this effect [84], [87], while 
others [37], [38] use Michaelis-Menten kinetics where plasmin is the catalyst and 
unbound/deactivated fibrin is the product. A difficulty with fibrinolysis, and perhaps the reason 
it is not often used, is that it is not clear what effect this reducing fibrin concentration will have 
on the clot. Clearly it will reduce the mechanical strength of the thrombus, but to what extent 
and at what level is not well understood. Anand proposed that a fibrin concentration of 600 
nM/L should be the threshold below which a clot can be said to have dissolved or broken up 
[37].  
 
The second direction is based on mechanical rather than chemical lysis, and is called 
thrombolysis. This erosion is due to stresses on the surface of the thrombus caused by the 
flowing blood. In order to find the shear stress levels at which clots begin to break up and 
fracture, Riha used a rotational rheometer and freshly clotted human blood to generate 
experimental results [92]. Haematocrit (volume fraction of red blood cells) of the blood samples 
was controlled to three levels, with lower haematocrit leading to more fracture resistant clots. 
For a haematocrit of 40%, a shear stress of 211 ± 43 Pa was found, and this value was used 
in a following computational model by Anand as the limit for clot dissolution [37]. Colace used 
a microfluidic device to test the shear rate at which embolization occurs from thromboses with 
and without fibrin. Clots with fibrin were significantly more resistant, demonstrating a maximum 
shear rate of 80 000 s-1 [93]. All these papers emphasize that the shear stress at which 
thromboses rupture or embolize is dependent on the concentration of fibrin and platelets within 
the clot, however, none present an explicit relationship between these variables. 
 
Virag attempted to take this into account by including a fibrin degradation rate which is 
proportional to plasmin concentration and inversely proportional to fibrin concentration and 
mechanical strEtc.h. Notably this model also included the first order degradation of platelets 
deep within the thrombus [5]. 
 
 
Figure 18 - Mechanical properties of thromboses grown in various blood and plasma types [92] 
1.9.5 Vessel Size and Environment 
In reality, every aneurysm is unique, varying considerably in size, aspect ratio, position, degree 
of asymmetry, and overall shape. The geometry of the flow domain is one of the most 
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important factors to consider for thrombosis modelling because this geometry affects flow 
patterns and shear stresses and these in turn will affect enzyme transport, thrombolysis, 
platelet activation Etc. [30]. Kadri investigated injured blood vessels without aneurysms, and 
showed that geometric features such as vessel diameter and injury length dictate the 
maximum volume of a thrombus [89]. One can assume these features will be significant in the 
presence of an aneurysm too. 
 
Ideally, computational models would treat each patient on a case-by-case basis and adjust 
the geometry to be physiologically representative. Rayz used patient specific geometry and 
blood flow conditions to model intracranial aneurysms of three patients which were initially 
free of thromboses. After several months, the clots had grown, and MR imaging showed good 
correlation between the regions of these clots and the regions with slow or recirculating flow 
in the haemodynamic simulation [48]. This result shows that accurate thrombosis simulations 
are possible even without bio-chemical coagulation reactions, provided the haemodynamic 
model has sufficient refinement. 
 
Where patient-specific geometry is unavailable or where the focus is on other parts of the 
simulation, it can be useful to use a representative or typical geometry for AAAs. Unlike 
intracranial aneurysms which are typically saccular, AAAs are usually spindle or fusiform in 
shape [3]. As mentioned previously, surgical intervention usually occurs when the AAA grows 
larger than 5cm in diameter so it is more useful to simulate AAAs smaller than this, yet large 
enough to generate noticeable flow vortices.  
 
Finol used an aortic diameter of 1.6 cm and a fusiform aneurysm with a maximum diameter of 
4.8 cm which was offset from the centreline by various distances to study the effect of 
asymmetry. The results showed that with increasing asymmetry, the wall shear stress on the 
distal side of the aneurysm midpoint increased and the flow vortices changed size and position 
[76]. 
 
Virag used an idealised axisymmetric fusiform geometry which has an interesting mechanism 
where the aneurysm can grow in diameter yet the lumen of the blood vessel remains a 
constant diameter due to the immediate deposition of thrombus in the extra space. No 
dimensions were given for this particular study [5]. 
 
Biasetti used an axisymmetric fusiform geometry with inlet and outlet vessel diameter of 2 cm 
and maximum aneurysm diameter of 4.4 cm. The study argued that results from 2D and 3D 
simulations of this geometry were similar enough to warrant the use of a half-plane from 
central axis to vessel wall as the flow domain. An interesting addition to this study was to vary 
the size and position of the aneurysm wall which was treated as ‘injured’. In this injured zone, 
TF:VII complex has a concentration of 1e-6 nM which triggers the coagulation cascade, 
whereas the rest of the vessel was left as inert. A larger injured region showed increased 
thrombin concentration as expected, but notably when the injured zone was placed at the 
proximal neck of the aneurysm, the region of peak thrombin was still in the distal half of the 
aneurysm bulge. This ties in with clinical observations, which show the bulk of ILT thickness 
to be in the distal half of fusiform aneurysms [75]. 
 
Another finding of this paper was to show the birth, movement, and destruction of toroidal 
vortexes in fusiform aneurysms as shown in Figure 19, and following from that, the way in 




Figure 19 - Initiation and movement of vortical structures during one heartbeat pulse [75] 
 
Figure 20 - Effect of vorticity (Lambda 2) on distribution of thrombin (IIa) [75] 
1.9.6 Boundary Conditions 
In any fluid dynamics simulation, the boundary conditions are key. In order to create a useful 
and well-defined simulation, one must first know exactly what the boundary conditions are in 
reality, and then apply them in a way which balances accuracy and computational simplicity. 
In the case of the aorta, simulations typically have one inlet which defines velocity based on 
the cardiac output, one or multiple outlets (depending on whether the model takes into account 
arteries which branch off the aorta), and finally the wall of the blood vessel which in reality is 
flexible but is most often modelled as a rigid geometry.  
Page 32 
 
1.9.6.1 Inlet Velocity Profile 
A unique problem for patient-specific models of haemodynamics in blood vessels is the 
collection of accurate flow data. Invasive methods are obviously problematic, especially for 
patients already at risk of aneurysm rupture or embolization, so various studies have sought 
to use non-invasive methods to derive values of flow rate over time. The graph of flow rate 
over time for the duration of one heartbeat shall be referred to as the flow waveform. 
 
One of the early attempts was conducted by Mills in 1970 by means of direct catheterisation. 
The result showed an initial peak during systole followed by a secondary pulse of lesser 
magnitude [94]. Despite more accurate measurement technology, this profile was still in use 
recently. Finol et al. normalised the period to 1 second and used discrete Fourier transforms 
to represent the waveform as a function in their computational model [76]. 
 
 
Figure 21 - Aortic flow waveform based on [94] used by [76] 
Another popular waveform was derived using Magnetic Resonance Imaging velocimetry in an 
anatomically accurate physical model of the abdominal aorta. This work by Moore in 1994 
showed a similarly smooth curve but with a less pronounced second pulse [95]. This waveform 
with a period of 0.9 seconds was used by Taylor with the addition of a particular spatial velocity 
distribution at the inlet [96].  
In constant laminar flow within a straight pipe, the velocity will take a parabolic profile if given 
time to fully develop, this is known as Poiseuille flow. If, however, the flow is pulsatile, the 
inertial effects of the back-and-forth motion will cause the velocity profile to take on more 
complex shapes. The significance of this effect is quantified by the dimensionless Womersley 
number which is dependent on a length scale, frequency of pulsatility and kinematic viscosity 
[97]. In the aorta, the Womersley number is estimated to be 13.2, and it has been shown that 
changes in the Womersley number will alter the wall shear stresses found in simulations of 
blood flow in arteries [98]. While the use of Womersley profiles for inlet flow is clearly 
beneficial, it does add a layer of complexity to the simulation. Standard Womersley profiles 
exist for sinusoidally pulsatile flow, as shown in Figure 22 below, however for complex 
transient changes like in the Mills waveform, profiles would need to be calculated from the first 
principles of Womersley’s work. Various papers claim to incorporate Womersley profiles into 
their inlet boundary conditions, however, details on how this is achieved were not provided in 





Figure 22 –Velocity profiles for sinusoidal waveform with varying Womersley number [99] 
Recently, Phase Contrast Magnetic Resonance Imaging (PCMRI) has had a huge impact on 
blood flow rate measurement. This non-invasive technique has been developed to find blood 
flow rates in-vivo, with good temporal and spatial accuracy. The mechanism can be used to 
develop patient-specific flow waveforms for research and routine clinical applications [100]. 
Arzani used this method to find patient-specific flow rates in the descending aorta, and 
combined these with Womersley profiles to create the inlet boundary conditions for their model 
[2]. Callaghan used a similar approach to find flow waveforms for 6 healthy subjects [101] and 
Di Achille [4] used a waveform from Les [102] which has promise to be the replacement for 
Mills and Moore as the new standard for haemodynamic research in the aorta. The waveform 
presented by Les used PCMRI to find the average flow rate in the infrarenal and supraceliac 
aorta of 36 elderly patients with abdominal aortic aneurysms. Many previous studies were 
based on smaller groups of healthy individuals, so this work is especially valuable and apt for 
haemodynamic simulations of AAA. Average period of the waveform was 0.95 seconds. 
1.9.6.2 Outlet boundary condition 
Where the vessel wall is modelled as a flexible boundary, then the hydrostatic pressure of the 
fluid will change the stress on the wall and hence the shape of the flow domain [103]. Where 
multiple outlets exist, for example when including the minor arteries branching off the aorta, it 
is important to ensure that the model accurately captures the proportional split of blood flow 
to each branch [4]. In both these cases a methodology known as the Windkessel model is 
usually employed to represent flow impedance and reflected pressure waves from the 
downstream vasculature at the outlets. Where the boundaries are rigid and only one outlet 
exists, then the velocity field can be calculated accurately without the Windkessel model [104]. 
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For simplicity, a constant pressure outlet condition is typically used. The value of this pressure 
is arbitrary, seeing as only the difference in pressure between inlet and outlet is relevant to 
the simulation. The combination of a specified velocity (transient or steady) at the inlet and 
zero pressure at the outlet is a very common way to set up the haemodynamic problem in 
simulations of blood flow in the aorta [47], [75], [76], [101].  
 
2 Methodology 
2.1 Mathematical Model 
Given that this simulation deals only with the aorta, the scale of the flow domain is large 
enough to warrant the assumption of Newtonian behaviour for blood. The porosity of the 
thrombus was represented by altering permeability of computational cells within the clot by 
means of the 𝑘 value un equation 2.1. The effect of including porosity fraction (also known as 
volume of fluid) is discussed on page 57. The entire simulation domain was treated as an 
incompressible fluid defined by the Navier-Stokes equations with the addition of the Brinkman 




+ ∇ ⋅ (𝜌?⃗??⃗?) = −∇𝑝 + ∇ ⋅ 𝜏 −
𝜇
𝑘
 ?⃗?         (2.1) 
𝛿𝜌
𝛿𝑡
+ ∇ ⋅ (𝜌?⃗?) = 0           (2.2) 
?⃗? = f(t) |𝑖𝑛𝑙𝑒𝑡   ;    𝑝 = 0 |𝑜𝑢𝑡𝑙𝑒𝑡          
Where: 
𝜌 is the density of the fluid, ?⃗? is the velocity vector, 𝑝 is pressure, 𝜏 is the stress tensor, 𝜇 is 
viscosity, 𝑘 is permeability and 𝑓(𝑡) is a function describing the pulsatile flow velocity of a 
heartbeat. 
 
The enzymes thrombin, fibrinogen, and fibrin were treated as massless scalars within the fluid 




= ∇(?⃗? ⋅ [𝑇ℎ]) + 𝐷𝑡ℎ ⋅ ∇
2[𝑇ℎ] ;      [𝑇ℎ] = 𝑓(𝑡) 𝑖𝑛 Ω𝐴  (2.3) 
𝛿[Fg]
𝛿𝑡
= ∇(?⃗? ⋅ [𝐹𝑔]) + 𝐷𝐹𝑔 ⋅ ∇
2[𝐹𝑔] − 𝑆([𝑇ℎ], [𝐹𝑔])   (2.4) 
𝛿[Fn]
𝛿𝑡
= ∇(?⃗? ⋅ [𝐹𝑛]) + 𝐷𝐹𝑛 ⋅ ∇
2[𝐹𝑛] + 𝑆([𝑇ℎ], [𝐹𝑔])   (2.5) 
 
Where: 
[𝑇ℎ] is the concentration of thrombin, [𝐹𝑔] is the concentration of fibrinogen, [𝐹𝑛] is the 
concentration of fibrin, 𝐷[ ] is the diffusion coefficient of each substance respectively, 𝑆 
represents the source function for Michaelis-Menten kinetics as shown in equation 1.4, and 
Ω𝐴 represents the zone adjacent to the aneurysm bulge where thrombin concentration varies 
in time according to the function 𝑓. 
These differential equations which govern fluid flow and scalar transport are discretised in the 
following way [105]: 
• The flow domain is divided into discrete control volumes by using a computational grid 
or mesh. These control volumes may also be called cells. 
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• The governing equations are integrated over each individual control volume to 
construct algebraic equations for the discrete dependent variables (in this case 
pressure, velocity, and the scalar concentrations of thrombin, fibrin, and fibrinogen)  
• Linearization of the discretised equations by means of second order upwinding for 
velocity and scalar concentration and second order spatial discretization for pressure. 
• Second order implicit temporal discretisation to solve the linear equations at 
successive time steps 
The finite volume method was used for the discretisation described above. A pressure-based 
solver was used with second order upwinding for momentum and first order upwinding for 
scalar transport.  
 
2.2 Fluid Boundary Conditions 
As discussed earlier, where the fluid flow domain is a rigid geometry with one inlet and one 
exit, it is appropriate to use boundary conditions of zero pressure at the outlet and a defined 
velocity or flow rate at the inlet. Including turbulence modelling would have been beneficial for 
accuracy and completeness, however, due to time and computational constraints it was 
omitted. Womersley profiles would have been another desirable addition for the inlet velocity 
profiles, but this was omitted in favour of a parabolic profile typical of fully developed steady-
state laminar flow. This significantly simplified the model, and can be justified based on the 
observation that the flow velocity naturally develops into profiles resembling Womersley 
profiles over time. The inlet region is of sufficient length to allow the fluid to develop the 
characteristics of pulsatile flow which Womersley profiles aim to represent. In order to 
demonstrate this visually, the flow velocity profile was captured at the inlet and a surface just 
proximal to the aneurysm neck at three time points. These time points are 2.9, 3.13 and 3.34 
seconds – corresponding with peak systole, reverse flow at late systole, and early diastole.  
 
 




Figure 24 - Flow profiles at late systole (3.13 sec) 
 
Figure 25 - Flow profiles at early diastole (3.34 sec) 
 
Flow rate over time was taken from Les and is shown in  below. The flow at the infrarenal 
section of the aorta was used, as this area is particularly prone to AAAs. This waveform has 




Figure 26 - Flow rate in the aorta during one heartbeat [102] 
In order to use this experimental data in a numerical simulation, there are two possible 
strategies. The first is to use a table of values for flow rate at given times. The solver will use 
its current time to look up the nearest flow rate and time values, then interpolate from these to 
find a value for flow rate at that time step. The limitation of this method is that it does not lend 
itself to cyclic conditions. Flow rate and time values must be specified for the total duration of 
the simulation. Not only is this  labour-intensive, but it cannot be run indefinitely. The second 
option is to convert the data for flow rate into a function with time as a variable and flow rate 
as the solution. This has the advantage of greater control over the outcome and no end-time 
limit on the simulation. Given that flow from the heart is periodic, Fourier series are commonly 
used to represent the waveform.  
 
According to Les, their experimental waveform can be reduced to a 12 mode Fourier series, 
however, the details were not given in the paper [102]. An attempt was made using the multi-
variable solver in Microsoft Excel to find the parameters for this series. The only constraint on 
this solver was to maintain an equal value at the beginning and end of the waveform to ensure 
continuity over multiple pulses. The goal was to minimise the L2 norm of the error between 
function and experimental results. After many iterations the resulting 12 mode Fourier series 
had an error value of 1.70%. The standard Fourier series takes the form shown in equation 
2.6 below: 
 
𝑄(𝑡) = 𝑎1𝑆𝑖𝑛(𝑏1 ⋅ 𝑡 + 𝑐1) + a2Sin(b2 ⋅ t +  c2)+ . . + a12Sin(b12 ⋅ t +  c12)   + d           (2.6) 
 




Table 2 - Coefficient values for 12 mode Fourier series representing pulsatile flow 
Bearing in mind that this function will be solved each time step, it is vital to reduce 
computational expense if possible. This motivated an investigation into an alternative function 
which could accurately represent the experimental waveform more efficiently.  
 
The first attempt was to remove the modes with minimal effect on the total series. These were 
those with a comparatively small 𝑎 value such as modes 1 and 3. The next step was to multiply 
the whole series by an exponential function of the form 𝑔(𝑡) = 𝑎 ⋅ 𝑒𝑏⋅𝑡+𝑐. A negative value for 
𝑏 ensures that the role of this exponential function is to create larger amplitudes at the 
beginning of the waveform, and reduced amplitudes at the end of the waveform. Initially this 
produced good results: an error of just over 2% was achieved with only 4 modes. The problem 
with this method only became apparent during the mesh independence study. Fine meshes 
motivated the use of small time steps, but as time steps became smaller unusual flow spikes 
emerged within the first moments of the simulation. Some details of the waveform had been 
invisible in the excel analysis because the time resolution used for the curve fitting and 
waveform graph was too coarse. Only by monitoring velocity at each time step in the Fluent 
solver did the unwanted oscillations emerge.  
 
Sharp changes in velocity over a few milliseconds are not desirable in a haemodynamic 
simulation because they generate sharp spikes in pressure and shear rate and may also slow 
or prevent convergence of the solver. The exponential function was causing an unwanted 
spike in the first few milliseconds of the waveform, so it was discarded in favour of non-
exponential functions. A linear function showed some benefit, but a sinusoidal function showed 
the most promise. Ultimately the best performing function was a combination of the two, this 
function is shown in equation 2.7 below with variable values in : 
 
𝑄(𝑡) =  (𝑎1 ⋅ 𝑆𝑖𝑛(𝑏1 ⋅ 𝑡 +  𝑐1) + … + 𝑎4 ⋅ 𝑆𝑖𝑛(𝑏4 ⋅ 𝑡 +  𝑐4) +  𝑑 ⋅ 𝑡 +  𝑒) ⋅ 
(𝑎5 ⋅ 𝑆𝑖𝑛(𝑏5 ⋅ 𝑡 +  𝑐5)  +  𝑓 ⋅ 𝑡 +  𝑔)         (2.7) 
 
 
Table 3 – Coefficient values for custom pulsatile velocity function 
  
 1 2 3 4 5 6 7 8 9 10 11 12 
a -0.003 0.384 -0.018 3.624 -0.562 -2.669 0.205 -2.771 -0.278 -0.397 0.384 0.939 
b 0.034 1.750 1.061 0.767 44.88 20.49 8.394 21.15 17.85 23.32 43.58 44.39 
c -1.546 0.460 -0.522 1.328 -0.893 -8.287 0.278 -5.484 -3.962 -3.495 -9.533 -6.878 
d -3.809 
 1 2 3 4 5  d -4.56441 
a 8.09423 7.1611 -6.73674 -6.50845 -0.05959  e 3.89766 
b 12.90847 13.75438 28.53115 28.92759 9.1563  f -0.09942 





Figure 27 - Inlet flow waveforms based on experimental work and optimised functions 
As seen in Figure 27 above, the custom function represents the experimental data closely. It 
has an error norm of 3.0% compared to the 1.7% of the 12 mode Fourier series. This value 
was deemed to be acceptable for the purposes of this simulation. Given that only 5 Sinusoidal 
functions are used rather than 12, this function is expected to be significantly faster to solve. 
The problematic effect of using this custom function is that special care must be taken with 
the input variable, namely flow time. A pure Fourier series would generate a cyclic output for 
indefinitely increasing time, however the custom function only generates an appropriate output 
for time values between 0 and 1. However, the limitation of the custom function can be treated 
in such a way that actually benefits the flexibility of the haemodynamic model. 
 
The strategy is to convert the simulation flow time to a pseudo time between 0 and 1 and use 
this pseudo time in the custom function to calculate flow rate. This conversion is a surprisingly 
simple function that has the added benefit of introducing the variable of heart rate. The details 
of the function can be seen in the UDF section of the appendix, but essentially the wave form 
can be scaled horizontally to any length of time simply by changing one variable value. The 
value of this feature is that it allows the model to be quickly and easily adjusted for patient-
specific heart rates. Even within the course of a simulation, the heart rate can be varied with 
negligible computational cost, opening up opportunities for investigation into the effect of heart 
rate on thrombus growth.   
2.3 Chemical Boundary Conditions 
Three chemical species were incorporated into the model as massless scalar quantities in the 
fluid continuum. These species were the glycoproteins fibrinogen, fibrin, and thrombin.  
2.3.1 Fibrinogen 
Fibrinogen is always present in the bloodstream at fairly high concentrations. A concentration 
of 7000 nM/l from Bodnar was used for this model [38]. The entire fluid domain was initialised 
with this concentration, and during the simulation the incoming fluid also has a Fibrinogen 
concentration of 7000 nM/L. The outlet is treated as a constant Dirichlet boundary condition 
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with concentration of 7000 nM/L. Given that there is a brief period of reverse flow each 
heartbeat, the outlet will become the inlet momentarily and this fibrinogen concentration will 
propagate back into the flow field. The equal concentration at both outlet and inlet is based on 
the assumption that fibrinogen is not significantly depleted in the aneurysm region by the 
growth of a clot. Following some simulations with the full clotting model, the slow thrombus 
growth rate made it clear that this assumption is reasonable. 
 
Fibrinogen was advected with the velocity field as a massless scalar. Fick’s law was used to 
represent diffusion due to Brownian motion. The effect of hindered diffusion within the clot (as 
discusses in section 1.9.4.4) was neglected for the sake of computational simplicity. The 
diffusion coefficient for Fibrinogen in blood was either taken from Bodnar [38], as 𝐷𝐹𝑔 =
3.1 𝐸 − 7 𝑐𝑚2/𝑠, or the over-diffusive condition of 𝐷𝐹𝑔 = 10 𝐸 − 5 𝑐𝑚
2/𝑠 from Biasetti [75]. The 
choice will be clarified in the results section. Reaction of fibrinogen proceeds according to 
Michaelis-Menten Kinetics, where the rate constants were taken from Bodnar [38] as 𝑘𝑐𝑎𝑡 =
3450 𝑚𝑖𝑛−1 and 𝐾𝑀 = 3160 𝑛𝑀 . Given that a fibrinogen molecule is converted directly to a 
fibrin molecule, the concentration of fibrinogen and fibrin should change by equal but inverse 
quantities. The formulas for the sink of fibrinogen and source of fibrin for a given computational 





= −3450 ⋅ [𝑇ℎ] ⋅
[𝐹𝑔]
3160+[𝐹𝑔]




= +3450 ⋅ [𝑇ℎ] ⋅
[𝐹𝑔]
3160+[𝐹𝑔]
     (2.9) 
2.3.2 Fibrin 
The initial concentration of fibrin in the entire domain is zero to represent a completely 
uncoagulated state. The function for the source of fibrin has been shown in equation 2.9 
above. Diffusion is treated in the same way as fibrinogen with a diffusivity constant of either 
𝐷𝐹𝑛 = 2.7 𝐸 − 7 𝑐𝑚
2/𝑠 from Bodnar [38] or 𝐷𝐹𝑛 = 10𝐸 − 5 𝑐𝑚
2/𝑠 from Biasetti [75].  
 
Convection is treated as a simple massless scalar in a fluid continuum. However, it should be 
noted that for fibrin specifically, this assumption represents a much greater simplification than 
for fibrinogen. While fibrin monomers are small enough to be washed along in the blood, they 
quickly polymerise into long chains and thick fibrils. These adhere to each other, platelets and 
endothelium to form resistant networks. When fibrin matures into a cross-linked mesh it has 
been found to resist high shear stress even in the absence of platelets. In this state, advection 
in the flow field and diffusion due to Brownian motion will reduce or totally cease. This implies 
that mature fibrin strands ought to be treated differently from free fibrin monomers. For the 
sake of simplicity though, this model treats all fibrin as unbound monomers. The increased 
viscous resistance of the thrombus (described in the chapter on permeability on page 57) 
could be considered a proxy for the fibrin polymerisation and cross-linking effects, as it will 
significantly reduce the flow velocity within the thrombus, and hence hinder the convection of 
fibrin. 
2.3.3 Thrombin  
As mentioned earlier, most recent computational models of Thrombosis have modelled the 
entire coagulation cascade as a collection of reactions with all the procoagulant and 
anticoagulant enzymes involved [37], [75], [85]. It is necessary to specify starting 
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concentrations and reaction rates for every substance and interaction, and when platelets in 
multiple stages of activation are included - the biochemistry can become quite complex and 
expensive to simulate. These concentrations and rate constants are typically based on 
population averages, so to tailor the model to a specific patient would require re-evaluation of 
some or all of these values. The testing necessary to achieve this seems to be prohibitively 
complex or impractical, as it has not been attempted or suggested in any of the reviewed 
literature. The model presented in this thesis uses a novel alternative approach to thrombin 
generation which would allow important features of patient-specific blood chemistry to be 
simulated with relative ease. 
 
The strategy is to simplify a thrombin generation curve from a CAT test for the patient in 
question to an explicit function in time. Hemker and Wagenvoord have developed an analytical 
function which can represent a patient-specific TG curve to high accuracy and contains only 
3 variables. These variables are peak thrombin concentration (PEAK), time to peak 
concentration (TTP), and endogenous thrombin potential (ETP) - which is the total quantity of 
thrombin produced or the area under the TG curve. This function for thrombin concentration 
over time is used as replacement or proxy for the biochemical model of the coagulation 
cascade. This approach makes patient-specific coagulation modelling significantly easier from 
a biochemical perspective because a blood test can reveal the three variables required to 
describe the evolution of thrombin production. It may also be more accurate than previous 
methods, as the thrombin generation is observed experimentally rather than simulated. 
 
The function to analytically describe the time course of thrombin concentration in a TG test 
was published as follows (copied by screen grab from the text) [106]: 
 
      (2.10) 
 
After careful analysis, it was found that equation 2.10 does not produce a TG curve with the 
appropriate shape. One would expect that if the ‘PEAK’ variable is 100nM/L then the maximum 
of the resulting function would be 100, the same for TTP and ETP. This, however, is not the 
case, so some modification is called for. Moving the second closing bracket to after the ETP 
term caused it to work perfectly, so presumably the function was meant to be in this form but 
was mis-typed.  below summarizes the results of the original function and the function with 
modified brackets. 
Table 4 - Results of modification to TG curve equation 








PEAK 367 26996 368 128 1361 128 
TTP 6.3 2.16 6.32 4 1.12 4.00 
ETP 2277 62554 2228 633 2706 631 
 
The values for input 1 came from Wu [70] and the values for Input 2 came from Ninivaggi [61] 
with TTP added. Based on these results, it can be concluded that the function as published 
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was accidentally mis-typed, and that the bracket should be moved to its correct place. The 
modified function is as follows: 
 




𝑒𝑥𝑝[−𝑒𝑥𝑝[−𝑒 ⋅ (𝑡 − 𝑇𝑇𝑃) ⋅ 𝑃𝐸𝐴𝐾/𝐸𝑇𝑃]]    (2.11) 
 
The values available for peak, ETP and TTP vary widely in the literature. The decision was 
made to use data that is both recent and originates from Dr Hemker’s research group at 
Maastricht University. An added advantage of these values is the short clotting time which 
fortunately reduced the total simulation time to manageable levels. The values from Bloemen 
[107] are shown in Table 5, along with the TG curve based on the modified formula in Figure 
28.  
Table 5 - Values used in Equation 2.11 to generate TG curve 
ETP (nM ⋅ min)  Peak (nM) Time-to-peak (min) 




Figure 28 - Thrombin concentration curve based on equation 2.11 and parameters from Bloemen 2018 
The challenge of this approach, however, is in the spatial complexity of applying this thrombin 
concentration function. In models which simulate the coagulation cascade this was not a 
problem because thrombin generation rate was calculated for every computational cell at 
every time step based on the presence of other substances. As these other substances are 
unevenly distributed, a region of thrombin generation will emerge only where sufficient 
chemical precursors are present. For example, Leiderman and Fogelson [60] created a model 
where thrombin can only be generated in the presence of sufficient prothrombin and 
prothrombinase. Prothrombinase was abundant within the clot and prothrombin was abundant 
in the flowing blood, so the region of overlap was found to be a narrow band at the edge of 
the clot. Dashkevich [32] showed that blood plasma is an excitable medium in which thrombin 
generation can vary in space and time. In quiescent plasma the region of peak thrombin 
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generation started at a TF coated surface then propagated out into the fluid like a wave. Both 
these studies show that the region of thrombin generation is a significant consideration in a 
biochemical model of thrombosis. 
 
CAT tests are done in a laboratory with a sample of stationary blood, so they represent the 
average values in the fluid as a whole. While they capture the temporal development of the 
coagulation biochemistry, they do not capture any spatial information. So in order to use the 
TG curve in a thrombosis model some assumptions must be made about the location of 
thrombin generation.  
 
One possibility is to specify the flux or concentration of thrombin at a boundary. Biasetti [75] 
took this approach with a fixed concentration of tissue factor at the aneurysm wall. Given that 
the output of a CAT test is static thrombin concentration over time, the flux boundary option 
was dismissed in favour of specifying the concentration of thrombin. The boundary 
corresponding to the concave region of the aneurysm bulge was selected as the site of 
thrombin concentration. The same region was used by Biasetti and can be thought of as the 
region where the endothelium is most damaged.  
 
This approach did not produce any blood clot in the simulation, and even when thrombin was 
maintained at its peak value for close to a minute, there was little or no transport of thrombin 
into the blood. The reason for this is most likely because the no slip condition ensures that 
velocity is zero and advection is negligible at this boundary, so the only mechanism driving 
thrombin into the fluid domain is diffusion. Even when higher diffusivity was used for thrombin 
in blood based on Biasetti’s over-diffusive values, it was not sufficient to generate a thrombus 
in reasonable time.   
  
The model was then modified to specify thrombin concentration in the first layer of cells 
adjacent to the endothelium of the aneurysm bulge. These cells, though only 0.04mm thick, 
experience the effect of convection as fluid flows through them. This in turn transports the 
thrombin more effectively away from the wall than pure diffusion. The result was noticeably 
faster thrombus growth and more widespread thrombin transport.  
 
The choice of locating the region of thrombin concentration at the aneurysm boundary will 
have various consequences for the thrombus growth over time. Hindered transport (applied to 
convection or diffusion) is a necessary feature of a thrombosis model, however it also means 
that as the clot grows, transport from the region of high thrombin to the growing edge of the 
thrombus will become more difficult. As the thrombus boundary moves further away from the 
endothelium one would expect to see thrombin concentration reduce and hence clot growth 
could slow or cease. This implies that the ultimate size and shape of the clot could be limited 
by the distribution and transport of thrombin. This mechanism of self-limitation has a basis in 
the literature [84], so this modelling strategy provides a means to investigate this phenomenon. 
This approach to the location of thrombin generation shall be called Strategy A in the results 
section.    
 
An alternative strategy, based on the findings of Leiderman and Fogelson [60], is to site the 
region of peak thrombin generation in a narrow band at the outer edge of the thrombus. This 
strategy would totally negate the effects of hindered transport within the thrombus, hence the 
self-limiting mechanism described above would no longer come into play. The availability of 
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thrombin at the growing edge of the thrombus is expected to increase the speed of growth, 
and increase the effects of advection on thrombin and fibrin distribution.  
 
With this strategy, one likely limitation on thrombus growth will be the reducing thrombin 
generation due to the TG curve, however this would only occur in the later part of the 
simulation. The only mechanism which will limit clot growth within the first few minutes is 
mechanical lysis. This strategy was implemented by specifying thrombin concentration (based 
on the TG curve) within the cells representing the shell and deposited platelets. 
 
The details of this method to localise thrombin generation are as follows. The thrombus region 
has three distinct zones, namely the bound platelet layer, shell and core. The bound platelet 
layer is always one computational cell thick and covers those areas of the thrombus boundary 
where shear stress is low, the shell is any region where fibrin concentration exceeds 600 nM/L 
but is less than the concentration necessary to be part of the core. This particular value of 
fibrin concentration which separates core from shell has not been discussed in the reviewed 
literature, so various values were tested in order to find one which would produce a shell of 
appropriate thickness. This concentration value shall be known as the boundary fibrin 
concentration (BFC) from now on. All computational cells which are designated as shell or 
platelet layer can generate thrombin. Generation is represented by finding the concentration 
of thrombin from the TG curve corresponding to the elapsed flow time, and applying it to all 
‘thrombin generating’ cells at the end of each time step. Diffusivity of Thrombin is either 6.47 
E-7 cm2/s from Bodnar [38] or 10 E -5 from Biasetti [75]. This thrombin methodology shall be 
called strategy B. 
 
2.4 Software 
The Ansys workbench suite of programs was used exclusively for this project. Space Claim 
was used to create the geometry, Mechanical for meshing, and Fluent 19.2 for simulation, 
compilation of user defined functions (UDFs), data output and visualisation of results. Initial 
simulations were done on a 4 core desktop PC, however, final simulations were run on the 
Lengau cluster at the Centre for high performance computing (CHPC) in Cape Town. A 24 
core compute node was used with remote visualisation of the Fluent user interface by means 
of a VNC client and SSH tunnelling. The simulation time was dramatically reduced by using 
the CHPC rather than the desktop PC, however, an actual value for speed-up was not 
calculated. A 9-hour simulation would cover 1 to 3 minutes of blood flow time depending on 
the various features of the model or time step strategy. 
2.5 Meshing 
The 2D axisymmetric geometry from Biasetti was used as the fluid flow domain. In that model, 
a mesh of 58 194 triangular elements was used with an element quality greater than 0.81. The 
mesh was refined near the blood vessel boundary with gradually decreasing cell size. 
Unfortunately no data is given on element sizing [75].  
 
For the fluid model presented here, a different meshing strategy was employed. Firstly 
rectangular elements were preferred over triangular ones for the following reasons:  
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• The Fluent meshing guide recommends the use of triangles in 2D and tetrahedrons in 3D 
only for complex geometry. For simple geometry, rectangles or hexahedrons are expected 
to be quicker and more accurate [108]. The fusiform aneurysm geometry is simple enough 
for rectangular elements to be the more appropriate choice.  
 
• A clotting simulation was carried out with both element types, and the triangular cells 
proved problematic for implementing the moving boundary method which represents 
thrombus growth and lysis. Some cells experienced unusually high or low shear stress 
which made the transition from thrombus to blood or vice versa unpredictable.  
 
• Rectangular cells have corners which are less sharp, and this was preferable for 
representing the smooth surface of the thrombus boundary. By the same logic, polygon 
cells would be even better, but these were not available in the meshing software used.  
All meshes incorporated inflation at the interface between a stationary boundary and the 
moving fluid. This inflation was based on a first layer in the order of 0.04-0.1 mm and a growth 
rate of 1.2 for 7 layers. Local refinement was implemented along the boundary of the aneurysm 
bulge where the thrombus will begin to grow. High mesh resolution is desirable in this region 
to capture the details of the irregular thrombus geometry. Further local refinement was 
considered necessary at the aneurysm neck due to high shear stress and rotational flow in 
this region. 
 
Figure 29 shows a detailed view of the mesh at the boundary in the centre of the aneurysm 
sac. The inflation layer is visible at the top edge, followed by a region of local refinement which 
gradually expands to the regular cell size. While the mesh is quadrilateral dominant, some 
triangles are included in order to improve overall cell orthogonality. 
 
 
Figure 29 - Detailed view of mesh at aneurysm wall 
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2.6 Solver Parameters 
Ansys Fluent 19.2 offers four options for solving the pressure and velocity terms of the 
discretized Navier-Stokes equations. These are called SIMPLE, SIMPLEC, PISO, and 
Coupled. SIMPLE is the default, however for transient flow simulations the PISO scheme is 
recommended by the developers [109]. This was tested with the Biasetti geometry, a time step 
of 0.002 seconds, a maximum cell edge size of 1mm and a pulsatile inlet flow. The maximum 
Courant number for this particular simulation was close to 1. The time taken to complete 25 
time steps is shown in Table 6 below. 
 
Method SIMPLE SIMPLEC PISO Coupled 
Run time (sec) 72 71 62 61 
Table 6 - Speed of pressure & velocity solution methods 
Clearly PISO and Coupled are closely matched, so various other parameters were adjusted 
for these two methods to see the results. Higher order term relaxation was applied to the 




61 seconds 60 seconds 
Table 7 - Effect of relaxation factor on speed 
Higher order term relaxation offers a small speed up, so it will be incorporated into future 
calculations. The difference between the Coupled and PISO solvers is small enough to be 
negligible, so initially the decision to go with PISO was made on the basis of the 
recommendation by the software developers. However, after further investigation of sensitivity 
to time-step size, that decision was reversed. More details on this in the next section. 
For the spatial discretisation of pressure, the solver offers four options. ANSYS documentation 
recommends the PRESTO! for incompressible flows with small body forces and porous zones 
[109]. This description closely matches that of the haemodynamic model used in this 
simulation. A timing test was done for 50 time steps, and the results in Table 9 show that 
PRESTO! is the fastest. Given that PRESTO! is recommended and shows good speed, it will 




Standard Second order  PRESTO! Linear 
Run time (sec) 129 124 120 124 




2.7 Grid Independence Study 
The purpose of a grid independence study is to minimise the error due to the discretization of 
the flow domain into small computational cells. Meshes of various refinement were generated 
and used to simulate an identical fluid problem. The problem was purely haemodynamic, with 
no porous zones or chemical transport. Two seconds of pulsatile flow were simulated using 
identical time steps. At the end of this time, variables describing haemodynamic features 
relevant to clotting were recorded. These variables are described below. 
1. Average shear stress over the entire concave surface of the aneurysm bulge  
2. Average strain rate over the entire concave surface of the aneurysm bulge  
3. Velocity at a point located within the distal region of the aneurysm bulge, roughly 8mm 
away from the vessel wall 
4. Maximum velocity anywhere in the fluid domain 
The original values for a coarse mesh, followed by the relative difference between the values 
of subsequent more refined meshes are shown in Table 9 below. 
 
Table 9 - Results of mesh independence study 
 
Typically the mesh is refined by a factor of 2 at each step, and a change of less than 2-5% 
between successive mesh refinements is considered sufficient for convergence [110]. 
However, doubling the number of cells is a large change, and can lead to unnecessarily fine 
meshes. A mesh is too fine if it slows computation time significantly in return for negligible 
improvements in accuracy. As seen above, the 48 000 cell mesh does not quite meet the 5% 
relative change criteria, but the 88 000 cell mesh is too fine with less than half a percent 
improvement in accuracy.  In order to find the optimum refinement, three meshes with cell 
counts between 48 000 and 88 000 were generated. Graphs showing the results of all the 
tested meshes are presented in Figure 30 below. 
Number of cells 1. Average 
shear stress 
2. Average 
strain rate  




15000 0.0638 Pa 22.2 s^-1 0.0170 m/s 0.136 m/s 
Relative change  
 26000 14.97% 12.43% -0.20% 7.00% 
 48000 -1.01% 0.92% 5.14% 0.55% 





Figure 30 - Response of key haemodynamic variables to mesh refinement 
From visual inspection it appears that anything above 60 000 cells is sufficient to guarantee 
mesh independence. A mesh of 64 000 cells was used for all future simulations. Detailed 
images of the mesh are shown in Figure 31 and Figure 32 below: 
 




Figure 32 - Close up view of mesh at aneurysm neck 
The standard mesh report from ANSYS fluent is as follows: 
 
Minimum Orthogonal Quality = 7.65989e-01; Maximum Aspect Ratio = 3.51811e+00 
 
To gain more insight into the quality of the mesh, histograms for various cell quality metrics 
were generated in ANSYS Mechanical. These metrics are orthogonality, aspect ratio, 
skewness and finally overall quality. The histograms for the 64 000 cell mesh appear below: 
 
 
Figure 33 - Histogram of cell orthogonality in final mesh 
As seen in Figure 33, Cell orthogonality is good. Figure 34 shows that most cells have close 
to perfect aspect ratio. However, cells in the inflation layer are thin in the radial direction 
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compared to the axial. This leads to some aspect ratios up to 3. Given that these cells typically 




Figure 34 - Histogram of cell aspect ratio in final mesh 
 
 
Figure 35 - Histogram of cell skewness in final mesh 
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Figure 35 shows that cells skewness is generally low and within reasonable bounds. Figure 
36 shows that the great majority of cells have a quality above 0.9, however, there are some of 
lower quality, most likely due to the aspect ratio imbalance mentioned above. Overall the mesh 
quality metrics show that the mesh is of a good standard and suitable for use in the fluid solver. 
 
Figure 36 - Histogram of overall cell quality in final mesh 
2.8 CFL Condition and Time Step Size 
The Courant-Friedrichs-Lewy (CFL) condition describes the maximum Courant number which 
a time stepping numerical method can use. The Courant number is a measurement of how 
much information traverses a computational cell in a given time, so in fluid dynamics this 
translates to flow velocity multiplied by time step size divided by the length of the cell. The 
purpose of checking the CFL condition for a given simulation is to find an appropriate time 
step size which is small enough to ensure convergence and accuracy, but not so small that 
the simulation takes longer than necessary. Speaking of higher or lower Courant numbers is 
analogous to using longer or shorter time steps [111]. 
 
For explicit schemes, a CFL<1 is a necessary condition for stability, however, the solvers used 
in ANSYS Fluent are implicit and therefore from a mathematical perspective are 
unconditionally stable. In reality though, computational limitations and non-linearities in the 
governing equations can lead to inaccuracy and instability if the time steps are too large. The 
question of “how large is too large” is not simple to answer, as the appropriate time step size 
is dependent on the nature of the problem being solved. In ANSYS Fluent the default Courant 
number for the coupled solver is 5, however, numbers above 100 are possible for certain 
situations [109]. No CFL condition is recommended for the PISO method in the literature, but 
when a Courant number above 2 was used to simulate a flow with a porous zone the solver 
quickly diverged. The coupled solver did not diverge even at much higher Courant numbers 




An additional topic in the search for computational speed and accuracy is matrix 
preconditioning and stabilization. Two of the most popular methods which are available in 
Fluent are BCGSTAB and GMRES. These methods improve the conditioning of the matrices 
used in the linear solver, the result being more stable with potentially faster convergence [112]. 
Some experiments were conducted to find the effects of these methods versus the standard 
coupled solver.  
 
One systolic pulse was simulated in the geometry from Biasetti [75] using the coupled solver 
and varying timestep sizes. No porous zone was present in this case. The values for various 
flow variables were recorded throughout the simulation. The L2 norm technique was used to 
reduce this time series to a single value for comparison. A solution with no stabilisation and a 
Courant number below 1 was used as the benchmark from which to test the accuracy and 
speed of other solutions. Where percentages are shown, these represent the variation from 
the benchmark. Speed-up is a dimensionless factor found by dividing the benchmark 






Strain rate Velocity at 
test point 
Speed-up 
1 None - - - None 
2 None 0.05917% 0.33276% 0.19772% 2.07 
 BCGSTAB 0.05917% 0.33276% 0.19772% 1.78 
 GMRES 0.05917% 0.33276% 0.19772% 1.23 
5 None 0.72958% 1.13593% 0.89934% 5.21 
 BCGSTAB 0.68296% 0.96732% 0.79049% 4.39 
 GMRES 0.67983% 1.13595% 0.89934% 3.67 
10 None 1.29547% 2.30860% 1.82259% 10.54 
 BCGSTAB 0.73662% 1.35198% 1.00335% 8.67 
 GMRES 1.29547% 1.15826% 1.82265% 6.07 
20 None 1.28031% 2.43038% 1.86963% 23.28 
 BCGSTAB 1.28032% 2.43030% 1.86957% 19.95 
 GMRES 1.28031% 1.44926% 1.86959% 14.32 
Table 10 - Effect of Courant number on simulation accuracy and speed 
When standard averaging was used rather than an L2 norm, errors were all below 1.5%. A 
comparison of peak values of each variable showed errors all below 0.2%. The results in Table 
10 show that even with a Courant number of 20, results can differ less than 2% from a Courant 
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number of 1. Considering the significant speed up obtained by larger time steps, an argument 
can be made that this small reduction in accuracy is an acceptable price to pay. 
 
Regarding stabilisation techniques, in this case they usually provided a minor improvement in 
accuracy for a minor cost in simulation time. BCGSTAB is consistently faster than GMRES, 
but accuracy shows no such consistent trend. When a porous zone was added to the flow 
domain in a later experiment, the effects of BCGSTAB versus no stabilisation were compared 
by observing the real time plot of residuals in the Fluent solver. The standard solver converges 
quickly initially, but slows exponentially with each iteration. When BCGSTAB is activated the 
residuals reduce rapidly and linearly, resulting in significantly faster convergence. This 
motivated the use of BCGSTAB for all future simulations.  
 
Unfortunately, the concept of a CFL condition becomes less useful and clear when considering 
a mesh with a wide range of cell sizes and a flow with unsteady velocity. The “worst case 
scenario” method would be to use the maximum velocity at any space and time, and the length 
of the smallest cell in the mesh. While this method was used in the previous time step analysis, 
it is worth remembering that this number may be unreasonably inflated due to the underlying 
assumptions. Two arguments against the use of this worst-case approach are described 
below. 
 
The first issue is the common practice of using inflation layers for extra cell refinement near 
stationary walls. The purpose of this refinement is to capture the high shear gradients caused 
by a viscous fluid flowing past a stationary surface. Assuming a no-slip condition at the 
boundary means that flow velocity approaches zero in the same region where cell sizes are 
becoming smaller. This means that the smallest cells will typically experience the lowest 
velocities, and larger cells in the centre of the domain will experience higher velocities. 
Generally this should lead to fairly consistent Courant numbers far below the worst-case 
scenario estimate.  
 
Another complication for analysis of Courant number is the pulsatile flow generated by the 
heartbeat. Inlet flow velocity is close to zero for much of the waveform and peaks only for an 
instant. If one selects a time step based on the Courant numbers at peak systole, it would be 
far too conservative for the diastolic period. Larger time steps during diastole are desirable in 
order to reduce overall simulation time.  
 
The strategy employed was to calculate the Courant number in every cell for various time 
step sizes and various flow rates. Four heartbeats were simulated to stabilise the flow field, 
then on the fifth beat, histograms were generated to illustrate the number of cells within a 
certain range of Courant number. Three points in time were selected for analysis, firstly 
maximum flow rate at peak systole, secondly a medium flow rate immediately after systole, 
and finally a low flow rate at late diastole. Time step size was varied at each of these 
moments with the aim to keep the Courant number below 3 in the majority of computational 
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cells. The points of investigation and time step sizes are shown in Figure 37 followed by 








Figure 38 - Courant numbers at point 1: Peak systole 





Figure 39 - Courant numbers at point 2: Early diastole 
 
Figure 40 - Courant numbers at point 3: late diastole 
Once appropriate time step sizes had been selected for each phase of the flow waveform, a 
user defined function was written to periodically adapt the time step size as shown in Error! 
Reference source not found. above.  
2.9 Model for Thrombosis 
In order to model the interaction between the thrombus and the haemodynamic environment, 
it is first necessary to keep track of the regions which are clotted and unclotted. For an extra 
layer of complexity, the region model should also differentiate between core and shell regions 
in the thrombus. This was achieved in ANSYS Fluent by means of a user-defined memory 
value for each computational cell. A numeric value is stored for each cell representing its 





Fluid Bound platelet layer Clot shell Clot core 
0 1 2 3 
  
The purpose of storing a value for each cell is to limit the thrombus growth to appropriate 
regions. The thrombus should propagate out from the damaged endothelium rather than 
simply emerging anywhere in the fluid where fibrin is present. The concept behind the three 
numerical values is based on the platelet adhesion and agglomeration mechanism described 
earlier in section 1.4. Platelets bind to endothelium or other platelets to form a layer in which 
fibrin strands can form. The cells with number 1 represent this region of bound platelets, and 
consequently a computational cell can only have a value of 1 if it is adjacent to a cell which is 
either thrombus shell or endothelium. This layer of bound platelets is also less stable due to 
the lack of mature fibrin, so it is limited to be no more than one computational cell thick. 
 
Once a cell containing bound platelets reaches a high enough concentration of fibrin, it 
changes to 2 and is now considered part of the thrombus shell. At this point the properties of 
the cell will change from the default for the fluid to those of thrombus shell. If fibrin 
concentration increases higher still, then the cell converts from shell to core, with properties 
changing accordingly.  
 
Similar models which have aimed to represent the haemodynamic differences between fluid 
and thrombus, and between core and shell, have relied on porosity fraction and/or viscous 
resistance. These two mechanisms can be applied separately in ANSYS Fluent, and result in 
modifications of the continuity and conservation of momentum equations as shown in 
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Where: 
𝛾 represents porosity fraction, 𝛼 is permeability, 𝐵𝑓 is the body force vector and 𝐶2 is the inertial 
loss coefficient. 
 
Tomaiuolo [84] claimed that porosity fraction and hindered diffusion were sufficient to model 
a thrombus, and permeability was not necessary. The porous model used in their study to 
investigate core and shell was static and used values of 0.2 and 0.4 respectively. Govindarajan 
[86] used variable permeability based on fibrin and platelet concentrations and neglected 
porosity fraction, the key difference being that this model was not static, and aimed to show 
thrombus growth over time. This difference between strategies for static and dynamic initially 
seemed arbitrary, however, the reason became clear as soon as an attempt was made to 
apply porosity fraction to a dynamic model of a growing thrombus. In the fluid region 𝛾 = 1 but 
in cells converted to thrombus 𝛾 = 0.7. Permeability was infinite for the fluid region and 𝛼 =
5.0 𝐸9 in the thrombus region. Figure 41 shows the results of 14 seconds of flow time with a 





High velocity jets emerged from within the centre of the thrombus, driving rapid movement of 
thrombin and fibrin away from the vessel wall. This led to rapid growth in some zones, and 
severe lysis in others, leading to a striated pattern. These jets fed into the luminal flow and 
raised the outlet flow rate to be orders of magnitude higher than the inlet flow rate. A visual 
inspection of the velocity field indicates that mass and momentum are not conserved over the 
simulation domain, however, at each time step the Fluent solver was converging to residuals 
below 5e-4 for continuity and velocity components. This implies that each cell was satisfying 
the modified continuity and momentum conservation equations (2.12 & 2.13) to sufficient 
accuracy, therefore the problem must originate with the equations themselves. 
 
A possible reason for this issue is the time derivative terms which contain 𝛾 in both the mass 
and momentum equations. Take for example the first term of the mass conservation equation 
(2.12). For a static porous region in an incompressible fluid, the first term 𝛿(𝛾𝜌)/𝛿𝑡 will always 
be zero. For a moving porous region, a cell can change porosity from one time step to the 
next, so 𝛾 is variable in time and 𝛿(𝛾𝜌)/𝛿𝑡  can be non-zero. This term represents the change 
in the mass of a cell over time, so for an incompressible fluid like blood it should always be 
zero. If a cell changes from fluid to shell, so that its porosity goes from 1.0 to 0.4 during a time 
step of 0.005, this term will now be in the order of 105 kg/(m3s). This will in turn affect the 
second term in equation (2.12) and then the conservation of momentum equation (2.13). The 
result is the physically unreasonable velocity field seen in Figure 41.  
 
While it may be possible to rewrite the governing equations so that porosity fraction can be 
included in a dynamic porous zone, that task was beyond the scope of this project. With the 
equations as they are applied in Fluent, it appears to be impossible to use porosity fraction in 
a zone of varying size. Given that a growing thrombus is a key feature of this model, and that 
Fluent had been selected as the ideal software for various other reasons, unfortunately 
porosity fraction had to be neglected from the thrombus model for all future simulations. 
 
Permeability is taken into account by altering the 𝛼 value in the conservation of momentum 
equation. The effect is to create a momentum sink which is proportional to velocity and 
inversely proportional to permeability. Fluent calls this effect viscous resistance, but it can also 
be referred to as the Brinkman term. Permeability values for core and shell were taken from 
Wufsus [90] and are based on experimental data of the constituent ingredients of an average 
Figure 41 - Failed attempt to implement variable porosity in growing thrombus simulation 
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clot. The core has a fibrin fraction of 49% and a platelet fraction of 12% according to Sadowski 
[72], which translated to a permeability value of  2 E-12 cm2. Tosenberger [43] claimed that 
the shell has lower fibrin concentration, however, it is not clear how this translates to a value 
for fibrin fraction. A fibrin concentration of 3% and a platelet concentration of 12% were 
selected resulting in a permeability that is two orders of magnitude greater than the core. This 
shell permeability of 2 E-10 cm2 is supported by the experimental work by Kim [71] which found 
that the shell permeability is roughly 100 times that of the core and is in the range of 10-12 to 
10-9. Inertial resistance was neglected due to lack of precedent and experimental data.  
 
A final mechanism of the model is lysis due to stress on the surface of the thrombus. Cells 
can only become thrombus shell or core when shear stress is sufficiently low, and they can 
revert back to fluid by the effect of high shear stress. A shear stress limit of 211 Pa was used 
based on the experimental work of Riha [92]. Observation during simulation showed that this 
value was close to optimal, as the thrombus could grow to fill the aneurysm sac and cause 
some stenosis, but never fully occlude the vessel. Lysis based on strain rate was not utilised 
as values observed in the flow were orders of magnitude lower than the 83 000 s-1 level 
recommended by Brass [77].  A diagram showing the criteria for conversion from one identity 
to the next is shown in Figure 42 below. 
 
 
2.10 Summary of Computational Strategy 
ANSYS Fluent is an efficient and detailed fluid dynamics solver which has many built-in 
features, however, for specific problems, additional customisation is necessary. User defined 
functions (UDFs) can be written in the C++ code language and compiled within fluent to adjust 
almost any feature of the fluid problem and the solver properties. The following is a pseudo-
code version of the computational methods implemented at each time step. The first step is 
completed by the Fluent solver, but the rest are implemented by custom UDFs.   
 
For each time step: 
 
1. Solve velocity and pressure field from previous time step so that velocity, scalar transport 
and continuity residuals are less than 10e-4 
Figure 42 - Modelling strategy for conversion from fluid blood to multi-zone thrombus 
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2. Calculate appropriate inlet velocity for time step based on flow rate waveform 
 
3. Apply flow rate to inlet boundary in the form of a parabolic velocity profile 
 
4. Calculate thrombin concentration based on function for TG curve 
 
5. Apply this value to the appropriate region where thrombin is being generated 
 
6. Loop over every computational cell and do the following: 
 
6.1. Calculate how much fibrinogen is converted to fibrin according to Michaelis-Menten 
kinetics 
 
6.2. Increase fibrin concentration and decrease fibrinogen concentration by this amount 
 
6.3. For cells containing bound platelets, if fibrin concentration is above 600, convert to 
shell 
 
6.4. For shell cells, if fibrin concentration is above 1500, convert to core 
 
6.5. For all fluid cells, if any neighbour is not fluid, become bound platelet layer. 
 
6.6. For all non-fluid cells, if shear stress in cell or any neighbour cell is greater than 211 
Pa, convert cell to fluid 
 
7. Find length of next time step based on adaptive step sizing function 
 
8. Write flow data to file and record image for animation 
 
9. End and move to next time step to repeat from 1.  
2.11 Summary of Fluid Values 
The following table shows the values used for all fluid and modelling variables used for the 
final simulations including the reference for the chosen value. 
 
Variable Value Reference 
Density of blood 1033 kg/m3 [43] 
Viscosity of blood 3.5 E-3 kg/(m s) [35] 
Porosity of clot core 0.35 [77] 
Porosity of shell 0.7 [77] 
Viscous resistance of clot core 2.0 E-12 m2 [90] 
Viscous resistance of clot shell 2.0 E-10 m2 [71] 
Minimum fibrin concentration to become clot shell 600 nM [37] 
Minimum fibrin concentration to become clot core 1500 nM [38] 
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Minimum shear stress for lysis 211 Pa [92] 
Minimum shear rate for lysis 83000 s-1 [77] 
Diffusion coefficient of thrombin 6.68 E-8 kg/(m s) [38] 
Diffusion coefficient of fibrinogen 3.20 E-8 kg/(m s) [38] 
Diffusion coefficient of fibrin 2.55 E-8 kg/(m s) [38] 
Blood concentration of fibrinogen 7000 nM/L [38] 
kcat for Michaelis-Menten reaction 3450 min-1 [38] 
KM for Michaelis-Menten reaction 3160 nM [38] 
Heart rate 66.6 bpm n/a 






3.1 Strategy A 
The two strategies for location of thrombin generation which were discussed at the end of 
section 0 are here named A and B. In strategy A the region of thrombin generation was 
restricted to the concave section of the aneurysm wall. The value for thrombin concentration 
was initially maintained at 300 nM/L in order to see the result of this strategy with high thrombin 
concentration at the boundary. The thrombin concentration was applied to a layer of 
computational cells adjacent to the vessel wall. Diffusivity was raised to the over-diffusive 
case, where all three chemical species have a diffusivity constant of 10−8 m2/s. The simulation 




The first thing to notice in Figure 43 is that the ILT has a consistent thickness, with slightly 
more volume on the proximal side. This indicates that the effects of advection have been 
negligible, as one would expect the flow from left to right to carry thrombin and fibrin 
downstream, thus promoting more thrombus growth in the distal region of the aneurysm. One 
of the key findings of Biasetti [75] was this specific feature, namely that ILTs grow larger in the 
distal region due to the effects of advection. The uniform thickness is consistent with purely 
diffusive transport, as pure diffusion would cause thrombin molecules across the concave 
boundary to spread at a uniform rate. As thrombin moves outwards, layers of fibrin will be 
generated and deposited over the entire ILT boundary, thrombin will advance slightly further 
by diffusion - and the process repeats. Distribution of thrombin is shown below in Figure 44, 
demonstrating that thrombin does indeed diffuse normal to the boundary in a uniform and 
consistent way despite the pulsatile flow conditions.   




The second key feature of this test was the concentration of fibrin within the thrombus. The 
plot of fibrin concentration in Figure 45 below shows that most of the ILT interior has the 
maximum fibrin content is 7000 nM/L. This figure is the maximum because fibrinogen 
concentration in the incoming blood is 7000 nM/L, and fibrin can only be formed by the 
conversion of available fibrinogen. This high concentration shows that fibrin generation is 
proceeding quickly within the ILT, but this does not translate to quick growth of the ILT volume. 
Again, this is probably due to the effect of slow diffusion and negligible convection, as the fibrin 
molecules have no way to escape the cell in which they are generated.   
 
The experiment was repeated, but this time with the thrombin concentration curve applied as 
the boundary condition rather than a fixed 300nM/L. Given that the peak thrombin 
concentration of this curve was 264.1 nM/L, and the initial value less than 10 nM/L, it was 
assumed that the ILT would grow more slowly than the previous test. This test would also 
show if the variable thrombin concentration has a corresponding effect on ILT growth rate. 
The evolution of ILT size and boundary thrombin concentration are shown in Figure 46 below. 
Figure 44 - Thrombin distribution for over-diffusive, high thrombin concentration environment using strategy A 




Figure 46 shows that ILT growth rate is largely independent of thrombin concentration. In fact, 
ILT growth is at its fastest when thrombin levels are relatively low. This demonstrates that 
even small quantities of thrombin can generate sufficient fibrin to drive clot growth. Over time 
the thrombus growth rate decreases at a uniform rate until it stalls at the 5-minute mark. This 
slowing growth could be due to various reasons. Firstly depletion of fibrinogen. This would 
explain why increasing thrombin makes no difference to growth rate, as it is no longer a limiting 
factor. A second option is that growth rate decreases as thrombus size increases. This would 
confirm the self-limiting mechanism of thrombus growth mentioned previously. As the 
thrombus/fluid boundary moves away from the vessel wall, less thrombin can reach it, so at 
some point there is insufficient thrombin to generate fibrin and the growth stops. A third option 
is the effect of mechanical lysis, which will be discussed in the next paragraph. Figure 47 
below shows the barely-visible thrombus after 150 seconds of flow time.  
 
 
Figure 47 - Final ILT and velocity vectors for strategy A with TG curve boundary condition 
Thrombus growth rate was found at each time step by calculating change in ILT volume over 





























































Thrombus size vs thrombin concentration over time
Thrombus size Thrombin concentration
Figure 46 - ILT growth for strategy A 
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growth rate is plotted against average inlet flow velocity in Figure 48 below in order to 
investigate the impact of mechanical lysis due to shear.  
 
From Figure 48 it is clear that growth rate is negative before and during early systole, then 
briefly positive during late systole. For the rest of the waveform growth rate is slightly positive. 
This graph is limited to the period from 76 to 79 seconds for clarity, but the pattern is consistent 
for most of the flow duration, with the ratio of negative growth to positive becoming greater 
later on. The mechanism responsible for this negative growth is lysis due to shear stress at 
the fluid/thrombus interface. Clearly the velocity at peak systole is high enough to cause lysis, 
but the lysis before systole is surprising and unexplained. What is clear is that the positive and 
negative growth peaks are remarkably similar in magnitude and duration, so a small change 
to either could alter the overall trend of thrombus growth. After roughly 5 minutes, the positive 
and negative growth are in perfect balance and the thrombus remains a constant size. 
 
While these results have shown some interesting features of the model, strategy A is not a 
suitable approach for simulating growth of ILTs. It is insensitive to thrombin concentration, the 
self-limiting of size is too extreme and the structure of the thrombus does not match 

















































Clot growth rate in relation to flow velocity
Growth rate Flow velocity
Figure 48 - Growth rate and flow velocity for strategy A with TG boundary 
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3.2 Strategy B 
For the first attempt using strategy B, the BFC was set at 3000 nM/L. The growth of the 
thrombus was more rapid than with strategy A, and showed a continuously increasing growth 
rate leading to full occlusion of the aneurysm sac within 30 seconds. BFC was then reduced 
to 1500 nM/L and finally 601 nM/L essentially removing the thickness of the shell layer. 
Occlusion times and growth rate were almost identical for all three, so 1500 nM/L was used 
for all subsequent simulations. Thrombus size and thrombin concentration are shown on 
Figure 49 below.   
A detailed view of thrombus growth rate in Figure 50 below shows that the magnitude of growth 
and lysis become more extreme over time. Between 20 and 28 seconds the thrombus had 
grown to fill the aneurysm sac and was beginning to encroach on the luminal region of the 
aorta. This constriction of the free-flowing area, known as stenosis, causes the velocity of the 
blood to increase in this region. Higher velocity leads to higher shear stress on the surface of 
the thrombus and hence more severe lysis, however, it is not obvious why the trend of growth 
rate clearly increases over this period. Either the increasing growth rate is linked to the 
increasing thrombin concentration, or there is some self-accelerating mechanism in the model 



































































Thrombus size vs thrombin concentration over time
Thrombin Concentration Thrombus size
Figure 49 - ILT size and TG curve for strategy B 
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To better understand the mechanisms driving thrombus growth, the period of observation was 
moved back to 20 seconds. At this point the thrombus had occluded roughly half of the 
aneurysm sac and was not experiencing the extreme lysis that accompanies full occlusion or 
stenosis. Figure 51 below shows that lysis does occur during early and late systole, most likely 
due to the rapidly changing velocity during these periods. During the diastolic period the 
thrombus grows rapidly, which contrasts with the negligible growth rate during diastole seen 
in the previous simulation. Another difference is that peak growth in the previous model was 
during late systole, whereas in this case growth rate is slightly negative during this period. 
These observations show that changing the location of thrombin generation leads to a 
fundamentally different relationship between the haemodynamic environment and the growth 























Thrombus growth rate over time
Figure 50 - ILT growth rate for strategy B 
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Visualisation of the flow velocity and shear stress was carried out at three points during a 
single heartbeat in order to clarify where lysis and growth are occurring.  
3.2.1 Point 1: Flow time = 20.8 seconds 
The first point is at 20.8 seconds, representing early systole and the moment when growth 
rate is close to zero. The flow field at this time is uni-directional and smooth, and the velocity 
around most of the ILT is low. The exception is the proximal edge of the thrombus, which is 
adjacent to a region of high velocity. In most of the following images black represents the 










































Thrombus growth vs inlet flow velocity
Average inlet velocity Clot growth rate
Figure 51 - Growth rate and velocity for strategy B between 20.7 and 22 seconds 
Figure 52 - ILT region and velocity vectors for strategy B at 20.8 sec 
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Closer investigation of the area marked ‘Detail 0’ in Figure 52 shows that the shear stress 
exceeds 211 Pa at the surface of the thrombus. This means that lysis is occurring at this part 
of the thrombus boundary. In Figure 53 the thrombus colours have been converted to 
greyscale to emphasise the colour contours of shear stress magnitude. 
 
 
3.2.2 Point 2: Flow time = 20.9 seconds 
The second moment of interest is at 20.9 seconds. This moment coincides with peak systole 
and a small spike in growth rate as evident in Figure 51. The flow field and thrombus region 
are shown in Figure 54 below. 
 
 
Naturally the luminal velocities are higher at peak systole as evidenced by the red velocity 
vectors, however the velocity over most of the ILT boundary is still low. The regions with high 
velocity have been analysed in more detail. In the region marked ‘Detail 1’ we can see that 
the region of high shear stress at the neck of the aneurysm has moved from the previous time 
point, leading to a reduction in lysis at the proximal edge of the ILT.  
Figure 53 - Shear stress at ILT boundary in ‘Detail 0’ area at 20.8 seconds 





Figure 55 - Shear stress at ILT boundary in ‘Detail 1’ area at 20.9 seconds 
In the area marked ‘Detail 2’, lysis is occuring over a small region of a protrusion of the 
thrombus. Note in Figure 56 the high shear stress at the distal boundary of the aneurysm sac 
which has prevented any thrombus growth in this region. 
 
 
Figure 56 - Shear stress at ILT boundary in ‘Detail 2’ area at 20.9 seconds 
These figures show that lysis decreases in one location and increases in another, so this does 
not yet explain the increase in growth rate at peak systole. A possible explanation is that higher 
velocities cause fibrin to exprerience greater convection from the thrombus shell out into to 
bound platelet layer. A faster supply of fibrin in the bound platelet layer will lead to rapidly 
incresing fibrin concentration and ultimately shell formation. Figure 57 below shows an overlay 




Figure 57 shows that fibrin is widely distributed outside the thrombus at concentrations 
approaching the 600 nM/L necessary for shell formation. A high velocity flow path appears to 
pick up fibrin as it passes the protrusion of the thrombus, this fibrin travels to the right and 
enriches a zone of high concentration (green). The region of slow velocity in the top left has 
much lower concentration of fibrin, which imples that the high velocity flow stream is directly 
responsible for a region of high fibrin concentration adjacent to the ILT boundary. The 
connection between this convection of fibrin and thrombus growth is demonstrated in Figure 
58 below.    
 
Figure 58 - Moving boundary of ILT in 'Detail2' region 
The black line represents the thrombus boundary at 20.9 seconds (peak systole) as seen in 
the previous image. The blue line shows the thrombus boundary at 21.0 seconds (end of 
systole). This profile indicates that the thrombus has grown most notably in the region of high 
fibrin concentration brought about by convection past the thrombus protrusion. This provides 
clarification on the increased growth rate during peak systole – essentially high velocity can 
Figure 57 - Fibrin concentration and velocity vectors in 'Detail 2' region at 20.9 seconds 
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promote rapid thrombus growth provided shear stress is below lysis levels and provided the 
boundary of the thrombus has some irregular geometry. 
 
The red line shows the boundary of the clot at 21,25 seconds. This coincides with early diastole 
and the maximum growth rate for this heartbeat cycle.  
3.2.3 Point 3: Flow time = 21.25 seconds 
The boundary has expanded in all directions, but the largest growth is at the sharp end of the 
protrusion. In the following figure we see that the same mechanism as before is at play. 
Convection of fibrin with the flow promotes faster clot growth in some regions than others, and 
these fast growth regions are generated by irregular geometry of the thrombus. 
 
 
Figure 59 - Fibrin concentration and velocity vectors in 'Detail 2' region at 21.25 seconds 
A wider view shows why the fluid is moving to the left in the image above. During diastole an 
anti-clockwise rotation emerges in the aneurysm sac. The curving reverse flow in the distal 
part of the aneurysm sac appears to be responsible for the growth of the protrusion seen 
above. The reverse flow over the thrombus surface carries thrombin and fibrin towards the 
aneurysm neck. This leads to the rapid growth of a structure indicated with an oval in Figure 
60. However, we have seen that the aneurysm neck is a site of high shear stress during 
systole, so this structure is completely removed by lysis during the following heartbeat. 
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Figure 60 - ILT region and velocity vectors at 21.25 seconds. Region of rapid proximal growth indicated. 
3.3 Vortical Structures and Thrombin Distribution 
Vortical structures due to transient flow within the aneurysm are a source of great interest in 
Biasetti [75]. Their simulation shows an anti-clockwise vortex forming at the aneurysm neck 
during systole, then travelling downstream during diastole until it ultimately breaks apart on 
the distal wall of the aneurysm sac. The vortical structures were not as clearly defined in the 
present model, most likely due to differences in the transient flow waveform, however the 
phenomenon described above does clearly occur. An added feature of the present model is 
the opportunity to see how these vortical structures influence the shape of the thrombus, both 
by creating the conditions for lysis and by affecting protein transport. In order to demonstrate 
this graphically, three consecutive time points are analysed in detail. The time points are 25.5, 
25.64 and 26.11 seconds. These points are shown on the graph of flow rate and thrombus 








































Thrombus growth vs inlet flow velocity
Average inlet velocity Clot growth rate





3.3.1 Point 4: Flow time = 25.5 s 
Flow separation at the aneurysm neck during peak systole gives way to a vortex in the same 
location as flow begins to slow. This anti-clockwise vortex is marked with an “x” in Figure 62. 
The vorticity magnitude at the same moment is shown in Figure 63. 
 
 
Figure 62 - ILT region and velocity vectors for strategy B at 25.5 sec 
 
Figure 63 - Vorticity magnitude for strategy B at 25.5 sec 
In Figure 62 above a concave depression is evident in the thrombus boundary which 
corresponds with the position and curvature of vortex. Is the vortex responsible for the shape 
of the boundary, or does the curvature of the boundary promote the formation of the vortex? 
Given that Biasetti [75] demonstrated the formation of a vortex in this position without a 
thrombus, it is more likely that the vortex is influencing the shape of the thrombus. Figure 63 





Figure 64 – High shear stress caused by vortex ‘x’ leading to localised lysis 
Figure 64 shows a close-up view of region of high shear stress on the thrombus surface 
corresponding to the position of the upper edge of vortex ‘x’. The shear stress is sufficient to 
cause lysis in this area, as indicated by the red colour and the absence of bound platelets at 
the surface of the ILT. The lower values of shear stress over the rest of the thrombus indicate 
that lysis is not occurring anywhere else. This indicates that a vortex can cause local lysis 
even when overall flow is too low to cause widespread lysis. It also demonstrates a clear link 
between the haemodynamic environment and dynamic re-modelling the thrombus boundary. 
 
But what about the influence of haemodynamics, and specifically vortices, on the biochemical 
environment? The following Figure 65 shows thrombin concentration at 25.5 seconds. The 
vortex marked “x” in Figure 62 is having a clear influence on the distribution of thrombin outside 
the ILT. The rotational flow drags the thrombin away from the region of generation and creating 
a region of high concentration at the centre of the vortex. Note the similarity to Figure 20 from 
Biasetti’s [75] simulation of thrombin movement in identical geometry. 
 
 
Figure 65 - Contours of thrombin concentration at 25.5 seconds 
A similar effect is shown for the distribution of fibrin in Figure 66. A region of high fibrin 
concentration to the left of the vortex is leading to the growth of a small protrusion. If the vortex 
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was stationary, this local growth would likely cause the ILT to form a concave boundary 
concentric with the vortex and tangential to the rotational flow. As we shall see at the next time 
step, the rapid distal movement of the vortex puts an end to the noticeable growth of this 
protrusion.   
 
3.3.2 Point 5: Flow time = 25.64 s 
During the brief period of reverse flow at the end of systole, the aorta and aneurysm show 
interesting flow patterns. Regions of recirculation emerge at multiple locations, most notably 
within the aneurysm sac where the vortex “x” expands to form a large rotating flow structure.  
 
 
Figure 67 - ILT region and velocity vectors for strategy B at 25.64 seconds 
A plot of vorticity shows the new location of vortex “x” close to the centre of the image. It should 
be noted that due to the axisymmetric assumption within the fluid model, this 2D Figure 68 
represents a slice through one side of a toroidal vortex. 




Figure 68 - Vorticity magnitude for strategy B at 25.64 seconds 
The region of high thrombin concentration has moved with the vortex away from the ILT 
boundary as shown in Figure 69. 
  
 
Figure 69 - Contours of thrombin concentration at 25.64 seconds 
Fibrin distribution is shown in Figure 70 below. The vortex “x” has carried a pocket of high 
concentration towards the central axis, however, smaller vortexes and flow paths are creating 
zones of fibrin concentration close to the ILT boundary. These regions of high concentration 
will translate to regions of rapid clot growth during the diastolic period. This effect will become 





Figure 70 - Contours of fibrin concentration at 25.64 seconds 
No lysis was occurring at this moment due to low shear at the ILT boundary, therefore a shear 
stress plot has been omitted. 
3.3.3 Point 6: Flow time = 26.11s 
The following images show conditions at late diastole, a time when bulk flow velocity is close 
to zero and thrombus growth rate is high. Regions of most notable growth are indicated by 
black circles in Figure 71 below. These regions correspond to zones of high fibrin 
concentration near the boundary of the ILT which are visible in Figure 70. 
 
 
Figure 71 - ILT region and velocity vectors for strategy B at 26.11 seconds 
The vortex “x” is still visible, however, the magnitude of the vorticity has reduced and various 
secondary vortexes “y” and “z” have emerged within the aneurysm. Note that vortex “x” has 
moved slightly downstream from its previous position. Within 0.1 seconds the acceleration 
from the systolic pulse will lead to smooth flow lines, and all these vortices will vanish. This 
indicates that the transport and lysis effects of the primary vortex “x” are limited to the distal 
half of the aneurysm sac in this simulation. If the period between one systole and the next was 
altered, the magnitude and positions of all three vortices at the end of diastole would be 





Figure 72 - Vorticity magnitude for strategy B at 26.11 seconds 
The following figure shows the distribution of thrombin concentration. The combined effect of 
vortices “x” and “y” are generating noticeable flow of thrombin into the blood stream in the mid-
distal region of the aneurysm sac. Convection of thrombin with flow was minimal with strategy 
A, however it is clearly evident with strategy B. This is desirable from the point of view of 
connecting haemodynamics to the biochemical clotting model. The following figure does, 
however, demonstrate a weakness in the implementation of this strategy in the current model. 
The region indicated with a black oval has emerged as a thrombus shell region during the last 
diastole, a period of roughly half a second. This protrusion will likely be removed by 
thrombolysis during the next systole, however this rapid local growth represents an anomaly 
which is not likely to occur in the human body. 
 
 
Figure 73 - Contours of thrombin concentration at 26.11 seconds 
The following figure shows that the protrusion in question has emerged because a large region 
of fluid has reached the sufficient fibrin concentration of 600nM/L almost simultaneously. This 
begins to explain the self-accelerating mechanism that has led to this unusual local growth. A 





Figure 74 - Contours of fibrin concentration at 26.11 seconds 
It has been shown in previous figures that irregular boundary geometry and/or flow vortices 
can create regions of high fibrin concentration outside the thrombus boundary. In reality this 
would lead to thrombus growth as the fibrin monomers join into fibrils and then create a mesh 
structure within or over the bound platelet layer. This process would proceed at some rate 
limited by the number of available platelets, level of platelet activation, and fibrin 
polymerisation time. The present model does not include the effect of these physiological 
constraints, instead growth rate is limited by a crude estimation inherent within the 
computational model. After each time step, the thrombus boundary can only expand into the 
bound platelet layer, shown in black above. This layer is never more than one computational 
cell thick, therefore growth rate is limited to the thickness of said cell per time step. A typical 
cell in this region shown above is 0.2mm, and during early diastole the time step size is 0.08 
seconds. If shear-based thrombolysis and availability of fibrin are not limiting factors, this leads 
to a hypothetical growth rate of 2.5 mm/s.  
 
This explains the potential for rapid growth, however the application of the thrombin generation 
model makes this occurrence more likely and leads to the accelerated growth of protrusions 
like that seen above. The aim of strategy B was to represent a band of thrombin generation 
limited by the overlap of prothrombin and prothrombinase as described by Leiderman and 
Fogelson [60]. If the thrombus boundary grew rapidly, the zone of overlap should narrow or 
cease to exist, and thrombin will no longer be generated. The strategy B model has the 
opposite response. As the thrombus grows, the generation region grows with it, leading to a 
greater quantity of thrombin in the region and high concentrations at the growing boundary. 
This high concentration catalyses the generation of fibrin which in turn causes the thrombus 
to grow more - and so the cycle continues. This self-accelerating feedback loop is the cause 
of local growth rates rising rapidly to their maximum possible value.   
3.3.4 Point 7: Flow time = 30.0 seconds 
Ultimately the ILT grows to fill the aneurysm sac and then continues to grow into the vessel 
lumen. This causes a stenosis of the vessel which reduces the effective area in which fluid 
blood can flow. This restriction leads to higher velocities adjacent to the aneurysm boundary 
and consequently higher shear stress. At this point the growth patterns of the thrombus 
change. Previously rotating vortices generated concave surfaces and protrusions, but now the 





The high shear stress due to stenosis leads to widespread thrombolysis over most of the 
aneurysm boundary, especially where protrusions were evident. This leads to the smoothing 
of the aneurysm surface and also the effective cessation of growth. The thrombus shell 
expands and contracts slightly during diastole and systole, but the competing effects of growth 
and lysis are balanced over the course of a heartbeat. A final point to note is the core 
dominates the volume of the thrombus, and the shell has become a thin layer of 1 or 2 cells. 
A plot of shear stress is shown in Figure 76 below.  
 
 
Figure 76 - Shear stress at ILT boundary causing widespread lysis at 30 seconds 
  





In this paper, a computational model has been introduced for simulating the growth of an ILT 
within an aortic aneurysm. The model combines the kinetics of the fibrinogen to fibrin reaction 
with a continuum model describing the fluid dynamics of the blood. Special attention has been 
given to fluid and chemical boundary conditions in order to enhance accuracy and create 
opportunities to include patient specific data. The ILT was treated as a porous zone in which 
intra-thrombus flow was hindered by variations in permeability. The commercial fluid dynamics 
solver ANSYS Fluent has been used for all simulation and visualisation. Mesh independence 
was confirmed with regard to the transient fluid flow, but not for the thrombus growth model. 
The solver was optimised for speed by testing for the optimum pressure-velocity coupling and 
pressure interpolation schemes. Overall simulation time was minimised by using a custom 
adaptive time stepping scheme and high-performance computing.   
 
Two strategies for applying a source of thrombin were tested, and the results showed that the 
thrombus boundary is far more effective as a zone for thrombin generation than the aneurysm 
wall. By using this strategy, an ILT exhibiting various spatio-temporal features consistent with 
human physiology was generated. Firstly, the thrombus grew until complete occlusion of the 
aneurysm sac, but not occlusion of the aorta itself. The maximum size caused slight stenosis 
of the vessel which is observed in some cases. Secondly, the thrombus exhibited core and 
shell morphology during growth which was similar to diagrams provided in other papers and 
similar to the results of other simulations [71], [77], [89]. The shell layer was removed by 
thrombolysis once the ILT encroached on the vessel lumen, leaving a dense core region as 
described by Tosenberger [43]. Thirdly, the boundary of the ILT during growth showed a 
dynamic response to the haemodynamic environment. Transport of chemicals by convection 
and thrombolysis by high shear stress played a significant role in shaping and re-shaping the 
ILT over time. Flow vortices within the aneurysm sac proved to have a significant effect on 
these processes, and they appear to be the key influencers of thrombus shape prior to full 
occlusion. The timing, size and position of these vortices showed close similarity to those 
generated by Biasetti [75] in identical geometry as demonstrated by the similarity between 
Figure 20 and Figure 65. Finally, the simulated thrombus showed a trend of larger ILT 
thickness in the distal compared to the proximal region. This effect was noticeable both before 
and after aneurysm occlusion, and confirms findings by Biasetti [75].  
 
This simulation can be used in its current form, or with some modification, to answer questions 
of interest to clinicians, engineers and biologists. One example would be to identify the regions 
of high risk for thrombosis growth around a medical device or surgical implant such as an 
artificial heart valve or endovascular graft. Another example would be to investigate the impact 
of variables such as heart rate or Endogenous thrombin potential (ETP) on the thrombus 
growth rate, morphology and size. However, before the model is put to use, certain limitations 
need to be understood or overcome – these limitations are discussed in the next paragraphs. 
 
The major flaw with the model is the surprisingly high growth rates which emerged under 
certain conditions. This effect occurred only in certain locations and at certain times, however 
it has the potential to undermine the accuracy of simulated thrombus size and growth rate. A 
modification to limit this self-accelerating growth mechanism is recommended before final 




One means to achieve this would be to slow growth everywhere by incorporating a simple 
time delay in the conversion from fluid to thrombus. Another addition which would slow growth 
indirectly, and conform the model closer to actual physiology, is to switch off thrombin 
generation for a period after the thrombus boundary has advanced. This would approximate 
the time for prothrombinase to diffuse from within the clot to the new boundary position. Finally, 
platelets could be included as an explicit substance within the flow. A minimum concentration 
of bound platelets could be included as a necessary requirement in the current thrombus 
growth model without much difficulty. By limiting the rate of platelet activation and binding, the 
overall thrombus growth rate would be limited based on sound physiological phenomena. 
 
A more general concern is the unclear connection between the changing thrombin 
concentration and the thrombus growth rate. With strategy A, growth rate slowed even as 
thrombin concentration increased, a counterintuitive response which implies a lack of coupling 
between the two. With strategy B growth rate did increase with thrombin concentration, though 
it is not clear whether this was due to coupling or the anomalous growth mechanism described 
above. Given that the ILT had ceased growing and was already high in fibrin concentration 
before the peak of the TG curve, it is reasonable to assume that subsequent increase or 
decrease of thrombin levels would have no effect on the thrombus shape or size. 
 
This implies that a close analysis of the fibrin reaction kinetics is recommended. With strategy 
B, fibrin generation was sufficient to grow the thrombus even when thrombin concentration 
was a tenth of its peak value. This could indicate that the Michaelis-Menten reaction was too 
sensitive to thrombin, or that the variables defining the TG curve were poorly scaled. Given 
the variability between results of CAT tests, calibration of the fibrin generation model based 
on TG results from a specific clinical context is recommended before use in said context.         
 
The major findings to come out of the creation of the model presented here are as follows. 
Firstly it is possible to generate ILTs with reasonably accurate overall shape and morphology 
without explicitly modelling the entire coagulation cascade. A thrombin to Fibrin model was 
shown to be sufficient for this purpose, however the selection of a suitable range for thrombin 
concentration is vital to generate accurate growth rates. Secondly, it was shown that the 
aneurysm wall is not as effective as the thrombus boundary as a site for thrombin generation. 
Even without hindered diffusion, the slow transport of thrombin led to a decrease in growth 
rate as thrombus thickness increased. This led to early cessation and insensitivity to the flow 
environment. Thrombin generation at the boundary, by contrast, led to rapid and continual 
growth and a dynamic response to the flow environment.  
 
In conclusion, the model presented here shows promise for the modelling of ILT in AAAs. 
Given the observed growth rates, the model at present is best suited to the types of ILT which 
grow within hours after surgery or injury, however, with modifications to the time advancing 
and thrombin release strategies, it could be used to model medium term growth over multiple 
days or weeks. It is suggested that the addition of a platelet activation and adhesion model 
would improve the accuracy of the model and correct the flaw in the thrombosis model which 
led to some regions of self-accelerating growth. It is hoped that the findings from this model 







[1] U. K. A. Sampson et al., “Estimation of global and regional incidence and prevalence 
of abdominal aortic aneurysms 1990 to 2010,” Global Heart. 2014, doi: 
10.1016/j.gheart.2013.12.009. 
[2] A. Arzani, G. Y. Suh, R. L. Dalman, and S. C. Shadden, “A longitudinal comparison of 
hemodynamics and intraluminal thrombus deposition in abdominal aortic aneurysms,” 
Am. J. Physiol. - Hear. Circ. Physiol., 2014, doi: 10.1152/ajpheart.00461.2014. 
[3] J. C. Lasheras, “The Biomechanics of Arterial Aneurysms,” Annu. Rev. Fluid Mech., 
2007, doi: 10.1146/annurev.fluid.39.050905.110128. 
[4] P. Di Achille, G. Tellides, C. A. Figueroa, and J. D. Humphrey, “A haemodynamic 
predictor of intraluminal thrombus formation in abdominal aortic aneurysms,” Proc. R. 
Soc. A Math. Phys. Eng. Sci., 2014, doi: 10.1098/rspa.2014.0163. 
[5] L. Virag, J. S. Wilson, J. D. Humphrey, and I. Karšaj, “A Computational Model of 
Biochemomechanical Effects of Intraluminal Thrombus on the Enlargement of 
Abdominal Aortic Aneurysms,” Ann. Biomed. Eng., 2015, doi: 10.1007/s10439-015-
1354-z. 
[6] F. Joly, G. Soulez, D. Garcia, S. Lessard, and C. Kauffmann, “Flow stagnation volume 
and abdominal aortic aneurysm growth: Insights from patient-specific computational 
flow dynamics of Lagrangian-coherent structures,” Comput. Biol. Med., 2018, doi: 
10.1016/j.compbiomed.2017.10.033. 
[7] K. C. Kent et al., “Analysis of risk factors for abdominal aortic aneurysm in a cohort of 
more than 3 million individuals,” J. Vasc. Surg., 2010, doi: 10.1016/j.jvs.2010.05.090. 
[8] N. Sakalihasan, R. Limet, and O. D. Defawe, “Abdominal aortic aneurysm,” Lancet. 
2005, doi: 10.1016/S0140-6736(05)66459-8. 
[9] D. A. Vorp, “Biomechanics of abdominal aortic aneurysm,” Journal of Biomechanics. 
2007, doi: 10.1016/j.jbiomech.2006.09.003. 
[10] P. M. Brown, D. T. Zelt, B. Sobolev, J. W. Hallett, and Y. Sternbach, “The risk of rupture 
in untreated aneurysms: The impact of size, gender, and expansion rate,” J. Vasc. 
Surg., 2003, doi: 10.1067/mva.2003.119. 
[11] M. F. Fillinger, S. P. Marra, M. L. Raghavan, and F. E. Kennedy, “Prediction of rupture 
risk in abdominal aortic aneurysm during observation: Wall stress versus diameter,” J. 
Vasc. Surg., 2003, doi: 10.1067/mva.2003.213. 
[12] J. Lindholt, S. Vammen, H. Fasting, E. Henneberg, and L. Heickendorff, “The plasma 
level of matrix metalloproteinase 9 may predict the natural history of small abdominal 
aortic aneurysms. A preliminary study,” Eur. J. Vasc. Endovasc. Surg., 2000, doi: 
10.1053/ejvs.2000.1151. 
[13] W. D. McMillan et al., “Increased plasma levels of metalloproteinase-9 are associated 
with abdominal aortic aneurysms,” J. Vasc. Surg., 1999, doi: 10.1016/S0741-
5214(99)70363-0. 
[14] L. Karlsson, D. Bergqvist, J. Lindbäck, and H. Pärsson, “Expansion of Small-diameter 
Page 84 
 
Abdominal Aortic Aneurysms is Not Reflected by the Release of Inflammatory 
Mediators IL-6, MMP-9 and CRP in Plasma,” Eur. J. Vasc. Endovasc. Surg., 2009, doi: 
10.1016/j.ejvs.2008.11.027. 
[15] S. R. Vallabhaneni, G. L. Gilling-Smith, T. V. How, S. D. Carter, J. A. Brennan, and P. 
L. Harris, “Heterogeneity of tensile strength and matrix metalloproteinase activity in the 
wall of abdominal aortic aneurysms,” J. Endovasc. Ther., 2004, doi: 10.1583/04-1239.1. 
[16] J. S. Wilson, L. Virag, P. Di Achille, I. Karšaj, and J. D. Humphrey, “Biochemomechanics 
of intraluminal thrombus in abdominal aortic aneurysms,” Journal of Biomechanical 
Engineering. 2013, doi: 10.1115/1.4023437. 
[17] A. K. Venkatasubramaniam et al., “A comparative study of aortic wall stress using finite 
element analysis for ruptured and non-ruptured abdominal aortic aneurysms,” Eur. J. 
Vasc. Endovasc. Surg., 2004, doi: 10.1016/j.ejvs.2004.03.029. 
[18] G. Mhlanga, “A retrospective audit into the morbidity and mortality of open abdominal 
aortic aneurysm repair at Groote Schuur Hospital, Cape Town,” University of Cape 
Town, 2017. 
[19] R. M. Greenhalgh, “Comparison of endovascular aneurysm repair with open repair in 
patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality 
results: Randomised controlled trial,” Lancet, 2004, doi: 10.1016/S0140-
6736(04)16979-1. 




[21] C. A. Taylor and M. T. Draney, “EXPERIMENTAL AND COMPUTATIONAL METHODS 
IN CARDIOVASCULAR FLUID MECHANICS,” Annu. Rev. Fluid Mech., 2004, doi: 
10.1146/annurev.fluid.36.050802.121944. 
[22] S. Roccabianca, C. A. Figueroa, G. Tellides, and J. D. Humphrey, “Quantification of 
regional differences in aortic stiffness in the aging human,” J. Mech. Behav. Biomed. 
Mater., 2014, doi: 10.1016/j.jmbbm.2013.01.026. 
[23] Blausen.com staff, “Medical gallery of Blausen Medical 2014.” [Online]. Available: 
https://en.wikiversity.org/wiki/WikiJournal_of_Medicine/Medical_gallery_of_Blausen_
Medical_2014. [Accessed: 01-Feb-2020]. 
[24] J. P. Vande Geest, M. S. Sacks, and D. A. Vorp, “The effects of aneurysm on the biaxial 
mechanical behavior of human abdominal aorta,” J. Biomech., 2006, doi: 
10.1016/j.jbiomech.2005.03.003. 
[25] A. Wills, M. M. Thompson, M. Crowther, R. D. Sayers, and P. R. F. Bell, “Pathogenesis 
of abdominal aortic aneurysms - Cellular and biochemical mechanisms,” European 
Journal of Vascular and Endovascular Surgery. 1996, doi: 10.1016/S1078-
5884(96)80002-5. 
[26] D. A. Vorp et al., “Association of intraluminal thrombus in abdominal aortic aneurysm 
with local hypoxia and wall weakening,” J. Vasc. Surg., 2001, doi: 
10.1067/mva.2001.114813. 
[27] D. H. J. Wang, M. S. Makaroun, M. W. Webster, and D. A. Vorp, “Effect of intraluminal 
thrombus on wall stress in patient-specific models of abdominal aortic aneurysm,” J. 
Page 85 
 
Vasc. Surg., 2002, doi: 10.1067/mva.2002.126087. 
[28] S. Sorrentino, “Radiopedia,” 2011. [Online]. Available: 
https://radiopaedia.org/cases/abdominal-aortic-aneurysm-35?lang=us. [Accessed: 01-
Feb-2020]. 
[29] J. Clauser et al., “A Novel Plasma-Based Fluid for Particle Image Velocimetry (PIV): In-
Vitro Feasibility Study of Flow Diverter Effects in Aneurysm Model,” Ann. Biomed. Eng., 
2018, doi: 10.1007/s10439-018-2002-1. 
[30] D. M. Sforza, C. M. Putman, and J. R. Cebral, “Hemodynamics of Cerebral Aneurysms,” 
Annu. Rev. Fluid Mech., 2009, doi: 10.1146/annurev.fluid.40.111406.102126. 
[31] F. Swieringa et al., “Platelet Control of Fibrin Distribution and Microelasticity in 
Thrombus Formation under Flow,” Arterioscler. Thromb. Vasc. Biol., 2016, doi: 
10.1161/ATVBAHA.115.306537. 
[32] N. M. Dashkevich et al., “Thrombin activity propagates in space during blood 
coagulation as an excitation wave,” Biophys. J., 2012, doi: 10.1016/j.bpj.2012.10.011. 
[33] D. A. Andrews and P. S. Low, “Role of red blood cells in thrombosis,” Current Opinion 
in Hematology. 1999, doi: 10.1097/00062752-199903000-00004. 
[34] S. Kattula, J. R. Byrnes, and A. S. Wolberg, “Fibrinogen and Fibrin in Hemostasis and 
Thrombosis,” Arteriosclerosis, Thrombosis, and Vascular Biology. 2017, doi: 
10.1161/ATVBAHA.117.308564. 
[35] F. Storti, T. H. S. van Kempen, and F. N. van de Vosse, “A continuum model for platelet 
plug formation and growth,” Int. j. numer. method. biomed. eng., 2014, doi: 
10.1002/cnm.2623. 
[36] M. Bryckaert, J. P. Rosa, C. V. Denis, and P. J. Lenting, “Of von Willebrand factor and 
platelets,” Cellular and Molecular Life Sciences. 2015, doi: 10.1007/s00018-014-1743-
8. 
[37] M. Anand, K. Rajagopal, and K. R. Rajagopal, “A model for the formation and lysis of 
blood clots,” Pathophysiol. Haemost. Thromb., 2006, doi: 10.1159/000089931. 
[38] T. Bodnár and A. Sequeira, “Numerical simulation of the coagulation dynamics of 
blood,” Comput. Math. Methods Med., 2008, doi: 10.1080/17486700701852784. 
[39] M. N. Ngoepe, A. F. Frangi, J. V. Byrne, and Y. Ventikos, “Thrombosis in cerebral 
aneurysms and the computational modeling thereof: A review,” Frontiers in Physiology. 
2018, doi: 10.3389/fphys.2018.00306. 
[40] N. Mackman, R. E. Tilley, and N. S. Key, “Role of the extrinsic pathway of blood 
coagulation in hemostasis and thrombosis,” Arteriosclerosis, Thrombosis, and Vascular 
Biology. 2007, doi: 10.1161/ATVBAHA.107.141911. 
[41] K. B. Neeves, D. A. R. Illing, and S. L. Diamond, “Thrombin flux and wall shear rate 
regulate fibrin fiber deposition state during polymerization under flow,” Biophys. J., 
2010, doi: 10.1016/j.bpj.2009.12.4275. 
[42] Z. M. Ruggeri, “Mechanisms of shear-induced platelet adhesion and aggregation,” 
Thrombosis and Haemostasis. 1993, doi: 10.1055/s-0038-1646171. 
[43] A. Tosenberger, F. Ataullakhanov, N. Bessonov, M. Panteleev, A. Tokarev, and V. 
Page 86 
 
Volpert, “Modelling of platelet–fibrin clot formation in flow with a DPD–PDE method,” J. 
Math. Biol., vol. 72, no. 3, pp. 649–681, Feb. 2016, doi: 10.1007/s00285-015-0891-2. 
[44] A. N. Sveshnikova, A. V. Belyaev, M. A. Panteleev, and D. Y. Nechipurenko, “The Role 
of Transmembrane Glycoproteins, Integrins and Serpentines in Platelet Adhesion and 
Activation,” Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 
2018, doi: 10.1134/S1990747818050070. 
[45] T. Lisman, C. Weeterings, and P. G. De Groot, “Platelet aggregation: Involvement of 
thrombin and fibrin(ogen),” Front. Biosci., 2005, doi: 10.2741/1715. 
[46] K. Ouriel et al., “The hemodynamics of thrombus formation in arteries,” J. Vasc. Surg., 
1991, doi: 10.1067/mva.1991.33157. 
[47] M. J. O’Rourke, J. P. McCullough, and S. Kelly, “An investigation of the relationship 
between hemodynamics and thrombus deposition within patient-specific models of 
abdominal aortic aneurysm,” Proc. Inst. Mech. Eng. Part H J. Eng. Med., 2012, doi: 
10.1177/0954411912444080. 
[48] V. L. Rayz et al., “Numerical modeling of the flow in intracranial aneurysms: Prediction 
of regions prone to thrombus formation,” Ann. Biomed. Eng., 2008, doi: 
10.1007/s10439-008-9561-5. 
[49] B. A. Zambrano et al., “Association of Intraluminal Thrombus, Hemodynamic Forces, 
and Abdominal Aortic Aneurysm Expansion Using Longitudinal CT Images,” Ann. 
Biomed. Eng., 2016, doi: 10.1007/s10439-015-1461-x. 
[50] A. A. Onasoga-Jarvis, T. J. Puls, S. K. O’Brien, L. Kuang, H. J. Liang, and K. B. Neeves, 
“Thrombin generation and fibrin formation under flow on biomimetic tissue factor-rich 
surfaces,” J. Thromb. Haemost., 2014, doi: 10.1111/jth.12491. 
[51] B. Savage, M. Cattaneo, and Z. M. Ruggeri, “Mechanisms of platelet aggregation,” 
Current Opinion in Hematology. 2001, doi: 10.1097/00062752-200109000-00002. 
[52] M. J. Slepian et al., “Shear-mediated platelet activation in the free flow: Perspectives 
on the emerging spectrum of cell mechanobiological mechanisms mediating 
cardiovascular implant thrombosis,” J. Biomech., 2017, doi: 
10.1016/j.jbiomech.2016.11.016. 
[53] L. F. Brass, “Thrombin and platelet activation,” Chest, 2003, doi: 
10.1378/chest.124.3_suppl.18S. 
[54] G. E. Jarvis, “Platelet Aggregation in Whole Blood,” in Platelets and Megakaryocytes: 
Volume 1: Functional Assays, J. M. Gibbins and M. P. Mahaut-Smith, Eds. Totowa, NJ: 
Humana Press, 2004, pp. 77–87. 
[55] Wikimedia Commons, “Coagulation with arrows for negative and positive feedback.,” 
2007. [Online]. Available: 
https://en.wikipedia.org/wiki/Coagulation#/media/File:Coagulation_full.svg. [Accessed: 
02-Feb-2020]. 
[56] H. H. Versteeg, J. W. M. Heemskerk, M. Levi, and P. H. Reitsma, “New Fundamentals 
in hemostasis,” Physiological Reviews. 2013, doi: 10.1152/physrev.00016.2011. 
[57] M. Hoffman, “A cell-based model of coagulation and the role of factor VIIa,” in Blood 
Reviews, 2003, doi: 10.1016/S0268-960X(03)90000-2. 
Page 87 
 
[58] T. Orfeo, S. Butenas, K. E. Brummel-Ziedins, and K. G. Mann, “The tissue factor 
requirement in blood coagulation,” J. Biol. Chem., 2005, doi: 10.1074/jbc.M505506200. 
[59] I. F. Obraztsov, Y. A. Barynin, and M. A. Khanin, “A mechanism for restriction of the 
activation-zone propagation for a hemostasis system (a mathematical model),” Dokl. 
Phys., 2000, doi: 10.1134/1.1342454. 
[60] K. Leiderman and A. L. Fogelson, “The Influence of Hindered Transport on the 
Development of Platelet Thrombi Under Flow,” Bull. Math. Biol., 2013, doi: 
10.1007/s11538-012-9784-3. 
[61] M. Ninivaggi, R. Apitz-Castro, Y. Dargaud, B. De Laat, H. C. Hemker, and T. Lindhout, 
“Whole-blood thrombin generation monitored with a calibrated automated 
thrombogram-based assay,” Clin. Chem., 2012, doi: 10.1373/clinchem.2012.184077. 
[62] H. C. Hemker et al., “The Calibrated Automated Thrombogram (CAT): A universal 
routine test for hyper- and hypocoagulability,” in Pathophysiology of Haemostasis and 
Thrombosis, 2002, doi: 10.1159/000073575. 
[63] R. S. Voronov, T. J. Stalker, L. F. Brass, and S. L. Diamond, “Simulation of 
intrathrombus fluid and solute transport using in vivo clot structures with single platelet 
resolution,” Ann. Biomed. Eng., 2013, doi: 10.1007/s10439-013-0764-z. 
[64] A. V. Belyaev, J. L. Dunster, J. M. Gibbins, M. A. Panteleev, and V. Volpert, “Modeling 
thrombosis in silico: Frontiers, challenges, unresolved problems and milestones,” 
Physics of Life Reviews. 2018, doi: 10.1016/j.plrev.2018.02.005. 
[65] A. S. Wolberg, “Thrombin generation and fibrin clot structure,” Blood Rev., 2007, doi: 
10.1016/j.blre.2006.11.001. 
[66] B. Dahlbäck, “Blood coagulation,” Lancet. 2000, doi: 10.1016/S0140-6736(00)02225-
X. 
[67] Y. Chugh, B. Lau, and C. C. Taub, “Early post-operative coronary thrombosis following 
repair of a proximal coronary artery fistula,” J. Clin. Diagnostic Res., 2016, doi: 
10.7860/JCDR/2016/22368.9106. 
[68] A. K. Ascoop and W. Budts, “Percutaneous closure of a congenital coronary artery 
fistula complicated by an acute myocardial infarction,” Acta Cardiol., 2004, doi: 
10.2143/AC.59.1.2005161. 
[69] K. Tzirakis, Y. Kamarianakis, E. Metaxa, N. Kontopodis, C. V. Ioannou, and Y. 
Papaharilaou, “A robust approach for exploring hemodynamics and thrombus growth 
associations in abdominal aortic aneurysms,” Med. Biol. Eng. Comput., 2017, doi: 
10.1007/s11517-016-1610-x. 
[70] W. T. Wu, M. A. Jamiolkowski, W. R. Wagner, N. Aubry, M. Massoudi, and J. F. Antaki, 
“Multi-Constituent Simulation of Thrombus Deposition,” Sci. Rep., 2017, doi: 
10.1038/srep42720. 
[71] O. V. Kim, Z. Xu, E. D. Rosen, and M. S. Alber, “Fibrin Networks Regulate Protein 
Transport during Thrombus Development,” PLoS Comput. Biol., 2013, doi: 
10.1371/journal.pcbi.1003095. 
[72] M. Sadowski, M. Zabczyk, and A. Undas, “Coronary thrombus composition: Links with 




[73] J. Silvain et al., “Composition of coronary thrombus in acute myocardial infarction,” J. 
Am. Coll. Cardiol., 2011, doi: 10.1016/j.jacc.2010.09.077. 
[74] M. N. Ngoepe and Y. Ventikos, “Computational modelling of clot development in 
patient-specific cerebral aneurysm cases,” J. Thromb. Haemost., 2016, doi: 
10.1111/jth.13220. 
[75] J. Biasetti, P. G. Spazzini, J. Swedenborg, and T. Christian Gasser, “An integrated fluid-
chemical model toward modeling the formation of intra-luminal thrombus in abdominal 
aortic aneurysms,” Front. Physiol., 2012, doi: 10.3389/fphys.2012.00266. 
[76] E. A. Finol and C. H. Amon, “Flow dynamics in anatomical models of abdominal aortic 
aneurysms: Computational analysis of pulsatile flow,” Acta Cient. Venez., 2003. 
[77] L. F. Brass and S. L. Diamond, “Transport physics and biorheology in the setting of 
hemostasis and thrombosis,” Journal of Thrombosis and Haemostasis. 2016, doi: 
10.1111/jth.13280. 
[78] K. Leiderman and A. L. Fogelson, “Grow with the flow: A spatial-temporal model of 
platelet deposition and blood coagulation under flow,” Math. Med. Biol., 2011, doi: 
10.1093/imammb/dqq005. 
[79] Wikimedia Commons, “Michaelis-Menten kinetics.” [Online]. Available: 
https://en.wikipedia.org/wiki/Michaelis–Menten_kinetics. [Accessed: 02-Feb-2020]. 
[80] R. C. F. Duarte, C. N. Ferreira, D. R. A. Rios, H. J. dos Reis, and M. das G. Carvalho, 
“Thrombin generation assays for global evaluation of the hemostatic system: 
perspectives and limitations,” Revista Brasileira de Hematologia e Hemoterapia. 2017, 
doi: 10.1016/j.bjhh.2017.03.009. 
[81] R. Loeffen et al., “Associations between thrombin generation and the risk of 
cardiovascular disease in elderly patients: Results from the PROSPER Study,” Journals 
Gerontol. - Ser. A Biol. Sci. Med. Sci., 2015, doi: 10.1093/gerona/glu228. 
[82] M. Smid et al., “Thrombin Generation in the Glasgow Myocardial Infarction Study,” 
PLoS One, 2013, doi: 10.1371/journal.pone.0066977. 
[83] K. E. Brummel-Ziedins and A. S. Wolberg, “Global assays of hemostasis,” Curr. Opin. 
Hematol., 2014, doi: 10.1097/MOH.0000000000000074. 
[84] M. Tomaiuolo, T. J. Stalker, J. D. Welsh, S. L. Diamond, T. Sinno, and L. F. Brass, “A 
systems approach to hemostasis: 2. Computational analysis of molecular transport in 
the thrombus microenvironment.,” Blood, 2014, doi: 10.1182/blood-2014-01-550343. 
[85] Z. Xu, N. Chen, M. M. Kamocka, E. D. Rosen, and M. Alber, “A multiscale model of 
thrombus development,” J. R. Soc. Interface, 2008, doi: 10.1098/rsif.2007.1202. 
[86] V. Govindarajan, V. Rakesh, J. Reifman, and A. Y. Mitrophanov, “Computational Study 
of Thrombus Formation and Clotting Factor Effects under Venous Flow Conditions,” 
Biophys. J., vol. 110, no. 8, pp. 1869–1885, Apr. 2016, doi: 10.1016/j.bpj.2016.03.010. 
[87] D. E. Lacroix, “A reduced equation mathematical model for blood coagulation and lysis 
in quiescent plasma.,” Int. J. Struct. Chang. solids - Mech. Appl., 2012. 
[88] ANSYS Inc., “ANSYS FLUENT 12.0 User’s Guide - 7.2.3 Porous Media Conditions,” 





[89] O. E. Kadri, V. D. Chandran, M. Surblyte, and R. S. Voronov, “In vivo measurement of 
blood clot mechanics from computational fluid dynamics based on intravital microscopy 
images,” Comput. Biol. Med., 2019, doi: 10.1016/j.compbiomed.2019.01.001. 
[90] A. R. Wufsus, N. E. MacEra, and K. B. Neeves, “The hydraulic permeability of blood 
clots as a function of fibrin and platelet density,” Biophys. J., 2013, doi: 
10.1016/j.bpj.2013.02.055. 
[91] R. W. Muthard and S. L. Diamond, “Blood clots are rapidly assembled hemodynamic 
sensors: Flow arrest triggers intraluminal thrombus contraction,” Arterioscler. Thromb. 
Vasc. Biol., 2012, doi: 10.1161/ATVBAHA.112.300312. 
[92] P. Riha, X. Wang, R. Liao, and J. R. Stoltz, “Elasticity and fracture strain of whole blood 
clots,” Clin. Hemorheol. Microcirc., 1999. 
[93] T. V. Colace, R. W. Muthard, and S. L. Diamond, “Thrombus growth and embolism on 
tissue factor-bearing collagen surfaces under flow: Role of thrombin with and without 
fibrin,” Arterioscler. Thromb. Vasc. Biol., 2012, doi: 10.1161/ATVBAHA.112.249789. 
[94] C. J. Mills et al., “Pressure-flow relationships and vascular impedance in man,” 
Cardiovasc. Res., 1970, doi: 10.1093/cvr/4.4.405. 
[95] J. E. Moore and D. N. Ku, “Pulsatile velocity measurements in a model of the human 
abdominal aorta under resting conditions,” J. Biomech. Eng., 1994, doi: 
10.1115/1.2895740. 
[96] C. A. Taylor, T. J. R. Hughes, and C. K. Zarins, “Finite element modeling of three-
dimensional pulsatile flow in the abdominal aorta: Relevance to atherosclerosis,” Ann. 
Biomed. Eng., 1998, doi: 10.1114/1.140. 
[97] J. R. Womersley, “Method for the calculation of velocity, rate of flow and viscous drag 
in arteries when the pressure gradient is known,” J. Physiol., 1955, doi: 
10.1113/jphysiol.1955.sp005276. 
[98] M. K. Banerjee, R. Ganguly, and A. Datta, “Effect of Pulsatile Flow Waveform and 
Womersley Number on the Flow in Stenosed Arterial Geometry,” ISRN Biomath., 2012, 
doi: 10.5402/2012/853056. 
[99] R. Hellmuth, “Womersley Flow Profile,” 2017. [Online]. Available: 
https://commons.wikimedia.org/wiki/File:Womersley_Flow_Profile.svg. [Accessed: 03-
Feb-2020]. 
[100] J. Lotz, C. Meier, A. Leppert, and M. Galanski, “Cardiovascular flow measurement with 
phase-contrast MR imaging: Basic facts and implementation,” Radiographics, 2002, 
doi: 10.1148/radiographics.22.3.g02ma11651. 
[101] F. M. Callaghan et al., “Use of multi-velocity encoding 4D flow MRI to improve 
quantification of flow patterns in the aorta,” J. Magn. Reson. Imaging, 2016, doi: 
10.1002/jmri.24991. 
[102] A. S. Les, J. J. Yeung, G. M. Schultz, R. J. Herfkens, R. L. Dalman, and C. A. Taylor, 
“Supraceliac and Infrarenal Aortic Flow in Patients with Abdominal Aortic Aneurysms: 
Mean Flows, Waveforms, and Allometric Scaling Relationships,” Cardiovasc. Eng. 
Technol., 2010, doi: 10.1007/s13239-010-0004-8. 
Page 90 
 
[103] H. H. Yeh, S. W. Rabkin, and D. Grecov, “Hemodynamic assessments of the ascending 
thoracic aortic aneurysm using fluid-structure interaction approach,” Med. Biol. Eng. 
Comput., 2018, doi: 10.1007/s11517-017-1693-z. 
[104] I. E. Vignon-Clementel, C. Alberto Figueroa, K. E. Jansen, and C. A. Taylor, “Outflow 
boundary conditions for three-dimensional finite element modeling of blood flow and 
pressure in arteries,” Comput. Methods Appl. Mech. Eng., 2006, doi: 
10.1016/j.cma.2005.04.014. 
[105] ANSYS Inc., “18.1 Overview of Flow Solvers,” ANSYS FLUENT 12.0 Theory Guide, 
2009. [Online]. Available: 
https://www.afs.enea.it/project/neptunius/docs/fluent/html/th/node360.htm. [Accessed: 
04-Feb-2020]. 
[106] R. M. W. Kremers, B. de Laat, R. J. Wagenvoord, and H. C. Hemker, “Computational 
modelling of clot development in patient-specific cerebral aneurysm cases: comment,” 
Journal of Thrombosis and Haemostasis. 2017, doi: 10.1111/jth.13591. 
[107] S. Bloemen, H. Kelchtermans, and H. C. Hemker, “Thrombin generation in low plasma 
volumes,” Thrombosis Journal, vol. 16, no. 1. BioMed Central Ltd., 15-May-2018, doi: 
10.1186/s12959-018-0164-6. 
[108] ANSYS inc., “ANSYS Meshing User’s Guide.” Canonsburg, PA, 2013. 




[110] S. Prakash and C. R. Ethier, “Requirements for mesh resolution in 3D computational 
hemodynamics,” J. Biomech. Eng., vol. 123, no. 2, pp. 134–144, 2001, doi: 
10.1115/1.1351807. 
[111] F. Giraldo, “Time Integrators,” Lecture notes. [Online]. Available: 
http://faculty.nps.edu/fxgirald/projects/nseam/nps/new_section4.pdf. [Accessed: 06-
Feb-2020]. 
[112] M. Fortin, H. Manouzi, and A. Soulaimani, “On finite element approximation and 
stabilization methods for compressible viscous flow,” Int. J. Numer. Methods Fluids, vol. 
17, pp. 477–499, 1993, doi: 10.1002/fld.1650170604. 
 
  
Page 91 
 
6 Appendix 
 
Page 92 
 
Page 93 
 
Page 94 
 
Page 95 
 
 
